Datenquellen im TIB-Portal   Hilfe zur Suche

Unser Tipp: Melden Sie sich an, um alle Funktionen im TIB-Portal optimal nutzen zu können!

PIN6 Evaluacion COSTO-Efectividad Del Uso De Linezolid En El Tratamiento De Neumonias Nosocomiales En MÉXICO (Englisch)

In: VALUE IN HEALTH   ;  14 ,  7  ;  A559  ;  2011
  • ISSN:
    1098-3015
  • Aufsatz (Zeitschrift)  /  Print

Wie erhalte ich diesen Titel?

© Metadata Copyright the British Library Board and other contributors. All rights reserved.

Inhaltsverzeichnis – Band 14, Ausgabe 7

Zeige alle Jahrgänge und Ausgaben

Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.

A234
DA1 Artificial Neural Network Meta-Models in Cost-Effectiveness analysis of intensive Blood-Glucose Control: A Case Study Applied to the UK prospective Diabetes Study (UKPDS) Individual Patient outcome Simulation Model
Alam, M. / Briggs, A. | 2011
A235
PC2 Estimation of Productivity Costs Using the Friction Cost Method: New Evidence Using National Data
Erdogan-Ciftci, E. / Koopmanschap, M. A. | 2011
A236
PR3 Industry Preparedness against German reforms
Devienne, E. / White, R. / Mukku, S. | 2011
A237
MT4 Mixed Treatment Comparisons Using Aggregate- and individual-Participant Level Data: An Efficient Use of Evidence for Cost-Effectiveness Modelling
Saramago, P. / Sutton, A. J. / Cooper, N. J. / Manca, A. | 2011
A238
UT1 Combining DCE and TTO Into A Single Value Function
Van Hout, B. A. / Oppe, M. | 2011
A239
VI3 Sequential Treatment of Follicular Non-Hodgkin Lymphoma: Cost-Effectiveness and Value of information
Soini, E. J. / Martikainen, J. A. / Vihervaara, V. / Mustonen, K. / Nousiainen, T. | 2011
A241
MA1 Mapping the EQ-5D Index from I-QOL in Idiopathic and Neurogenic OAB Patients: Results from A Cross-Sectional Study in the United States and Four European Countries
Kay, S. / Tolley, K. / Globe, D. / Piercy, J. / Anderson, P. | 2011
A242
MO2 Extrapolation in Oncology Modelling: Novel Methods for Novel Compounds
Annemans, L. / Asukai, Y. / Barzey, V. / Kotapati, S. / Lees, M. / Van Baardewijk, M. / Wang, Q. / Batty, A. J. / Fisher, D. | 2011
A243
RS3 Evidence, Process or Context? Examining The Factors That Drive Coverage Decisions Of Pharmaceuticals By Health Technology Assessment Bodies In Europe
Cerri, K. / Fern&#x00E1 / ndez, J. L. / Knapp, M. | 2011
A244
PMD4 Expert Elicitation to Populate Early Health Economic Models of Medical Diagnostic Devices in Development
Haakma, W. / Bojke, L. / Steuten, L. / Ijzerman, M. | 2011
A247
PMD20 Cost Analysis of Rechargeable Deep Brain Stimulator in Dystonia
Pr Coubes, P. / Fluck, L. / Topouchian, A. | 2011
A248
PMD25 Cost-Effectiveness of Transcatheter Aortic Valve Implantation (TAVI) in High-Risk or Inoperable Patients with Symptomatic Aortic Valve Stenosis in Spain
Ferreira-Gonz&#x00E1 / lez, I. / Serra, V. / Abdul, O. / Lizan, L. / Paz, S. / Banz, K. / Sureda, C. / Igual, A. / Garcia del Blanco, B. et al. | 2011
A249
PMD31 Economic Evaluation of Primovist versus Extracellular Contrast in Imaging of Liver Metastases of Colorectal Origin
Castell, J. / Bernal, C. / De Marcos, J. x. / Cugat, E. / Ram&#x00F3 / n, E. / Tellado, J. M. | 2011
A250
PMD37 Cost-Effectiveness of the Ex-Press Glaucoma Filtration Device in France
De jong, L. / Lafuma, A. / Cl&#x00E9 / ment, O. / Aguade, A. S. / Berdeaux, G. | 2011
A251
PMD42 Cost-Effectiveness of Using the UGT1A1 Pharmacogenetic Test to Reduce the Incidence of Irinotecan Chemotherapy-related Febrile Neutropaenia
Shabaruddin, F. H. / Elliott, R. A. / Tappenden, P. / Payne, K. | 2011
A253
PMD54 Resource Utilisation Related to Catheter-associated Urinary Tract infections in Swedish Spinal injury Patients
Bruce, S. / L&#x00F6 / froth, E. / Knutsson, B. / B&#x00F6 / rstell, T. / Myr&#x00E9 / n, K. J. | 2011
A254
PMD59 Complicated Parkinson'S Disease: Discrete Choice Analysis to Assess Patients' Preferences. A Pilot Study
Lloyd, A. J. / Herdman, M. / Gonzalez, P. | 2011
A255
PMD64 The Effect of Supplementary Fees on the Diffusion of Medical Devices in the German System of Diagnosis related Groups (G-Drg): The Case of Drug-Eluting Stents in Patients with Acute Myocardial Infarction
B&#x00E4 / umler, M. | 2011
A257
PMD75 Patient Self-Testing of Oral Anticoagulation Therapy by CoaguChek® XS System. Rapid Health Technology Assessment in Slovak Health Care Environment
Visnansky, M. / Mesaros, S. | 2011
A258
PMD80 Patient Demographics and Surgical Expenditure in Hernia repair Surgical Cohorts Using A retrospective Nationwide Patient Database
Hargreaves, J. A. / Nair, K. V. / Ghushchyan, V. H. / Allen, R. R. / Mcqueen, R. B. / Robinson, T. | 2011
A259
PMD85 Sleep Questionnaires Discriminate Between Participants With and Without Overactive Bladder Symptoms
Margolis, M. K. / Coyne, K. / Jumadilova, Z. | 2011
A260
PSU5 Risk of Arthritis as A Predictor for the Misdiagnosis of Chondrolysis: An International Analysis of Clinical Outcomes
Smith, J. C. / Provencher, M. T. / Solomon, D. J. / Navaie, M. | 2011
A261
PSU10 Economic Evaluation of Magnetic Resonance Guided Focused Ultrasound in Patients with Uterine Fibroids in Germany
Alvarez-Ossorio, L. / Burkowitz, J. / Nackunstz, I. / Brueggenjuergen, B. | 2011
A262
PSU15 the Economic Burden of Post-Transplant Events in Renal Transplant Patients in UK, Italy, Netherlands, Poland and Belgium
Sennfalt, K. / Ling, C. / Pericleous, L. / Sbarigia, U. / Gatta, F. / Kolasa, K. / Zagorska, A. / Chamberlain, G. / Pandit, P. | 2011
A263
PSU21 Speech Problem and Health-Related Quality of Life in Head and Neck Cancer Survivors After Five Years of Treatments
Payakachat, N. / Suen, J. Y. | 2011
A264
PSU26 Two-Year Changes in Generic and Obesity-Specific Quality of Life After Gastric Bypass
Mar, J. / Arrospide, A. / Mar, B. / Martinez de Arag&#x00F3 / n, G. / Karlsson, J. | 2011
A265
PIN3 Comparing the Efficacy and Tolerability of Anti-Retroviral Therapy in Treatment-Naïve HIV-1 Infected Adults: A Systematic review of Randomized Clinical Trials and Bayesian Mixed Treatment Comparisons Including Atazanavir/R, Darunavir/R, Lopinavir/R, and Efavirenz
Verheggen, B. / Vandeloise, E. / Treur, M. / Thuresson, P. O. / Lescrauwaet, B. | 2011
A266
PIN8 A Decision Tree Model Comparing Clinical Outcomes of Treatment with Telbivudine with or without “Tenofovir Add-on as Needed” and Lamivudine with or without “Tenofovir Add-on as Needed” in the Treatment of Chronic Hepatitis B Infection in Turkey
Ozdemir, O. / Saylan, M. / Pakel, H. / Lescrauwaet, B. | 2011
A267
PIN13 Epidemiology of Staphylococcus Aureus Infections in Children: A Literature Review of the Last 10 Years
Bricout, H. / Maier, W. / Mouchet, J. | 2011
A268
PIN18 Budget Impact Analysis of Tenofovir in Treatment of Chronic Hepatitis B (CHB)
Gwiosda, B. / Krzystek, J. / Rys, P. / Wladysiuk, M. / Mierzejewski, P. / Kazmierski, M. / Plisko, R. | 2011
A269
PIN24 Potential Costs Associated with New Direct Acting Antiviral (DAAs) Therapy for Untreated Chronic Hepatitis C Genotype 1 Infection in the Veterans Health Administration
Chan, K. / Lai, M. N. / Groessl, E. J. / Hanchate, A. / Hernandez, L. / Wong, J. B. / Clark, J. A. / Asch, S. / Gifford, A. L. / Ho, S. | 2011
A270
PIN31 Quantifying the Financial and Disease Burden Associated with Mother to Child Transmission of HIV in Uganda
Kuznik, A. / Semeere, A. / Sempa, J. / Auerbach, B. / Lamorde, M. / Castelnuovo, B. / Hermans, S. / Ssewankambo, F. / Ssennono, M. / Mpanga Sebuyira, L. | 2011
A271
PIN36 Surgical Site Infection Incidence and Burden Assessment Using Multi-Institutional Real-World Data
Delissovoy, G. / Pan, F. / Patkar, A. D. / Edmiston, C. E. / Peng, S. | 2011
A272
PIN41 Cost-Benefit Analysis of Regional Procured Essential Medicines in the Southern African Development Community (SADC) with a Focus on Access to Antiretroviral Drugs
Miller-Jans&#x00F6 / n, H. E. / Stander, M. | 2011
A274
PIN53 Cost-Effectiveness Analysis of Pegylated Interferon Alpha-2A Versus Pegylated Interferon Alpha-2B in the Treatment of Chronic Hepatitis C Patients in Poland
Macioch, T. / Paweska, J. / Niewada, M. / Berak, H. / Szkultecka-Debek, M. / Russel-Szymczyk, M. | 2011
A275
PIN58 Cost-Effectiveness Analysis of Pneumococcal 13-Valente Conjugate Vaccine Versus Pneumococcal 10-Valente Conjugate Vaccine in the Pediatric Immunization Routine, from the São Paulo State Public Health Care System (Brazil)
Pepe, C. / Teich, V. / Mould, J. F. | 2011
A276
PIN63 Cost-Effectiveness Analysis of Anti-Pneumococcal Vaccines in Panama
Lutz, M. A. / Luciani, K. / Morales, G. / Strutton, D. R. / Roberts, C. S. / Farkouh, R. A. / Cuesta, G. | 2011
A277
PIN68 Cost- Effectiveness Analysis of Human Papillomavirus Vaccination Program in Russia
Omelyanovsky, V. / Avxentyeva, M. / Krysanov, I. / Ivakhnenko, O. / Goryaynov, S. / Tsfasman, F. M. | 2011
A278
PIN73 Modeling the Long Term Clinical Outcomes and Health Care Cost Impact of Initiating Treatment with Atazanavir/R Compared with Darunavir/R, Lopinavir/R and Efavirenz for HIV-1 Infected Treatment-NaÏve Patients: Country Results for Italy, Spain, Portugal and UK
Thuresson, P. O. / Verheggen, B. / Heeg, B. / Aldir, I. / Carrasco, J. / Didoni, G. / Mesa, O. A. / Lescrauwaet, B. | 2011
A279
PIN78 Cost Utility of Infant Vaccination Against Respiratory Syncytial Virus Infection in the Netherlands
Meijboom, M. / Rozenbaum, M. / Benedictus, A. / Luytjes, W. / Kneyber, M. / Wilschut, J. / Hak, E. / Postma, M. | 2011
A280
PIN83 Cost-Effectiveness and Cost-Utility analysis of 200 Days Prophylaxis of Cytomegalovirus (CMV) infections in High Risk (D+/R-) Kidney Transplant Recipients in Poland
Kawalec, P. / Holko, P. / Boratynska, M. / Glyda, M. / Ignacak, E. / Russel-Szymczyk, M. / Szkultecka-Sebek, M. / Kaweczynska-Lason, A. | 2011
A282
PIN94 Assessment of Health Related Quality of Life (HRQOL) in Hepatitis- B Patients
Haq, N. / Shafie, A. A. / Hassali, M. A. / Ibrahim, M. I. / Saleem, F. | 2011
A283
PIN99 Modelling the Impact of Extended Vaccination Strategies on the Epidemiology of Pertussis
Rozenbaum, M. H. / De vries, R. / Postma, M. J. / Le, H. H. | 2011
A284
PIN105 Financial Support for HIV/AIDS Prevention, Care and Treatment in Thailand
Layton, M. R. / Pachanee, K. / Prakongsai, P. | 2011
A285
PIN110 Development of A Large Safety Database Using Studies Conducted During the Clinical Development and Post-Marketing of A Virosomal Aluminium-Free Hepatitis A Vaccine
Faure, C. / Koller, A. / Hartmann, K. / Chr&#x00E9 / tin, S. / Doux, S. / Vis&#x00E8 / le, N. / Bugnard, F. / Maier, W. | 2011
A286
PMH2 The Efficacy of the New Antidepressant Agomelatine as Compared Against Placebo and SSRIS: A Meta-Analysis Combining Published and Unpublished Data
Ballesteros, J. / Tarapues, M. / Santos, B. / Rueda, J. R. | 2011
A287
PMH7 Aasenapine Versus Other Antipsychotics in Bipolar I Disorder: Indirect Comparisons at Twelve Weeks
Sapin, C. / Corson, H. / Beillat, M. / Hansen, K. | 2011
A288
PMH12 Risk of Relapse and Hospitalization in the 2-Year Open-Label Treatment of Outpatients with Schizophrenia Randomized to Olanzapine Long-Acting Injection or Oral Olanzapine
Novick, D. / Ascher-Svanum, H. / Bertsch, J. / Detke, H. / Mcdonnell, D. / Witte, M. / Haro, J. | 2011
A289
PMH17 The Economic and Social Consequences of Schizophrenia Treatment with Seroquel XR® (Quetiapine Prolonged Release Tablets) in Poland: Aanalysis of the Impact on the Health Care System
Faluta, T. / Rdzanek, M. / Pierzgalska, K. / Wr&#x00F3 / bel, B. | 2011
A290
PMH23 The Economic Burden of Mental Ill Health in the Workplace: A Costing Approach for Brazilian Employers
Reis, T. C. / Takemoto, M. M. / Takemoto, M. L. / Fernandes, R. A. / Tolentino, A. C. / Cukier, F. N. / Santos, P. M. / Cruz, R. B. / Ribeiro, A. C. / Fernandes, R. R. | 2011
A291
PMH29 Cost Effectiveness of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Turkey in Patients with Major Depressive Disorder (Mdd) Who Have Failed Previous Antidepressant Therapy
Aydemir, O. / Dilbaz, N. / Malhan, S. | 2011
A292
PMH35 A Cost-Effectiveness Analysis of Paliperidone Palmitate Versus Olanzapine Pamoate in the Treatment of Schizophrenia in Norway
Einarson, T. R. / Vicente, C. / Zilbershtein, R. / Piwko, C. | 2011
A293
PMH40 Economic Evaluation of Agomelatine for Major Depressive Disorder in Australia
O'Leary, B. A. / Hamann, G. B. / Adena, M. A. | 2011
A294
PMH46 The Quality of Life of Children With ADHD and their Parents: Results of EQ-5D and Kidscreen-10
Van Der Kolk, A. / Bouwmans, C. / Schawo, S. / Buitelaar, J. B. / van der Gaag, R. J. / Van agthoven, M. / Hakkaart-van Roijen, L. | 2011
A295
PMH51 Measuring Relapse After Substance Abuse Treatment: A Proportional Hazard Approach
Ciesla, J. / Mazurek, K. | 2011
A296
PMH56 Negative Symptoms Have Greater Impact on Functioning Than Positive Symptoms in Schizophrenia: Analysis of Catie Data
Rabinowitz, J. / Garibaldi, G. / Levine, S. / Bugarski-Kirola, D. / Berardo, C. / Kapur, S. | 2011
A297
PMH61 A Descriptive Analysis of Atomoxetine Utilization in Attention Deficit/Hyperactivity Disorder (ADHD) the United Kingdom and Italy
Sikirica, V. / Mitra, D. / Fridman, M. / Davis, K. L. / Hodgkins, P. | 2011
A298
PMH66 12-Year Trend Analysis on the Characteristics, Primary Payer, and Prescribed Medications of Physician-Office Visits for Patients with Dementia in the United States
Chen, Y. J. / Sankaranarayanan, J. / Murman, D. L. | 2011
A300
PMH77 Prescription Pattern Evaluation for Bipolar Disorder in a Treatment Facility in India
Nagappa, A. N. / Kumar, M. / Noorunnisa, S. / Bhandary, P. V. / Veerupaksh, D. / Balakrishnan, R. | 2011
A301
PMH83 Estimating Utilities in Schizophrenic and Bipolar Patients from Disease-Specific or Generic Instruments Assessing Patients' Health States: Where are the Differences?
Cuervo, J. / Rebollo, P. / Maurino, J. / Cordero, L. / Castej&#x00F3 / n, N. | 2011
A303
PMS10 Evaluation the Risk Factors of Second Hip Fractures in the Elderly
Sebesty&#x00E9 / n, A. / S&#x00E1 / ndor, J. / Patzai, B. / G&#x00F5 / cze, K. / Kriszbacher, I. / Mint&#x00E1 / l, T. et al. | 2011
A304
PMS15 Costs of Tumor Necrosis Factor Blockers per Treated Patient Across Adult Indications Using Real-World Data in US Commercially-Insured Population
Schabert, V. / Gandra, S. R. / Watson, C. / Fox, K. M. / Yeaw, J. / Goodman, S. / Milev, S. / Harrison, D. J. | 2011
A305
PMS20 Treatment of Patients with Moderate and Severe Psoriasis – Cost-of-Illness in the Czech Republic
Petrikova, A. / Klimes, J. / Dolezal, T. / Marinov, L. / Petrova, G. | 2011
A307
PMS31 Cost-Effectiveness of Abatacept for the Treatment of Rheumatoid Arthritis (RA) After the Failure of a First TNF inhibitor in the United Kingdom
Pericleous, L. / Lebmeier, M. | 2011
A308
PMS36 Economic Analysis of Etanercept in Rheumatoid Arthritis from a Public perspective in Colombia
Fernandes, R. A. / Tovar, D. A. / Mould, J. F. | 2011
A309
PMS41 Assessing the Cost Effectiveness of Broadening Access to Alendronate for the Prevention of Osteoporotic Fracture in Australia
Tilden, D. / Jackson, D. / Tay-Teo, K. / Van Bavel, J. | 2011
A310
PMS46 Cost-Utility Analysis of Certolizumab Pegol versus Alternative Tumor Necrosis Factor-Inhibitors, for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Spain
Villoro, R. / Hidalgo, A. / Ferro, B. / Talavera, P. | 2011
A311
PMS51 A Cost Utility Analysis of Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
Adams, R. C. / Walsh, C. / Schmitz, S. / Barton, P. / Barry, M. | 2011
A312
PMS56 Subjective Health Expectations of Rheumatoid Arthritis Patients Starting Biological Therapy
Gulacsi, L. / Brodszky, V. / Baji, P. / Gulacsi, L. x. / P&#x00E9 / ntek, M. | 2011
A314
PMS67 Determining the True Impact of Dupuytren'S Disease: A Qualitative Study
Wilburn, J. / McKenna, S. / Crawford, S. R. / Perry-Hinsley, D. / Bayat, A. | 2011
A315
PMS72 Assessment of Prior Use of Prescribed Pain Medications Among Elderly Patients Who Initiated Duloxetine
Chen, S. Y. / Peng, X. / Wu, N. / Bernauer, M. / Rao, P. / Boulanger, L. / Zhao, Y. | 2011
A316
PMS77 Improving Quality and Reducing Costs in Workers' Compensation Health Care: A Population-Based Intervention Study
Wickizer, T. M. / Franklin, G. M. / Fulton-Kehoe, D. | 2011
A317
PND3 Risk-Benefit Analysis of Therapy in Multiple Sclerosis
Qizilbash, N. / M&#x00E9 / ndez, I. / S&#x00E1 / nchez-de la Rosa, R. | 2011
A318
PND9 The Role of Spontaneous Events Databases for Benefit-Risk Analysis
Qizilbash, N. / M&#x00E9 / ndez, I. / S&#x00E1 / nchez-de la Rosa, R. | 2011
A319
PND14 Comparing Expected Costs associated with Three Screening Strategies for Cystic Fibrosis Along Spain
Ramos-Go&#x00F1 / i, J. M. / Valc&#x00E1 / rcel-Nazco, C. / Castilla-Rodr&#x00ED / guez, I. / Espada-S&#x00E1 / enz-Torre, M. / Teller&#x00ED / a-Orriols, J. J. et al. | 2011
A320
PND20 A Cost-of-Illness Analysis Of Amyotrophic Lateral Sclerosis In Greece
Athanasakis, K. / Sideris, M. / Zacharis, M. / Rentzos, M. / Evdokimidis, I. / Kyriopoulos, J. | 2011
A321
PND25 Use of Drug Reimbursement as Markers of Disease for Epidemiological and Direct Cost analysis: The Case of Epilepsy in France
Fagnani, F. / Kusnik-Joinville, O. / de Z&#x00E9 / licourt, M. / Levy-Bachelot, L. / Branchoux, S. / Murat, C. / Bertrand, M. / Kahane, P. | 2011
A322
PND31 A Modelled Economic Evaluation of Firazyr® (Icatibant) for Symptomatic Treatment of Acute Attacks of Hereditary Angioedema (HAE) in Adults with C1-Esterase-Inhibitor (C1-INH) Deficiency
Tilden, D. / Cottrell, S. / Tocchini, L. / Jayaram, N. / Sinani, R. / Barnes, D. | 2011
A323
PND36 Factors Associated with Utility and Disutility Values in Relapsing Form of Multiple Sclerosis (RMS) Patients Using Data from Temso, A Teriflunomide Pivotal Phase III Trial
O&#x0027 / Connor, P. / Briggs, A. / Carita, P. / Bego-Le-Bagousse, G. | 2011
A324
PND41 Predicting EQ-5D Utility Scores from the Huntington quality of Life instrument (H-QOL-I)
Clay, E. / Briquet, B. / Aballea, S. / Maman, K. / Toumi, M. | 2011
A325
PND46 The Huntington Quality of Life Instrument (H-QOL-I): Cross-Cultural Validation in Germany, Poland and USA
Clay, E. / Mraidi, M. / Zielonka, D. / Cohen, J. / Toumi, M. / Auquier, P. | 2011
A326
PND51 The Relationship Between Patient-Reported Health-Related Quality of Life and Disability Status Among Patients with Multiple Sclerosis
Khalaf, K. M. / Globe, D. / Armstrong, E. / Malone, D. / Coyne, K. | 2011
A327
PND56 Quality of Life Assessments in Adults with Attention Deficit/Hyperactivity Disorder - A Systematic Review
Marfatia, S. / Shroff, K. / Munshi, S. / Tiwari, A. | 2011
A328
PND61 Impact of Patient Cost-Sharing Arrangements for Disease Modifying Therapies on Treatment Compliance among Patients with Multiple Sclerosis in the United States
Palmer, L. A. / Fowler, R. / Shi, N. / Dastani, H. / Abouzaid, S. / Kim, E. | 2011
A329
PND66 Cross-Cultural Adaptation and Validation of the Brazilian Version of the Fatigue Severity Scale (FSS)
Toledo, F. O. / Junior, W. M. / Speciali, J. G. / Sobreira, C. F. | 2011
A330
PUK3 Sources of Heterogeneity Among Overactive Bladder Clinical Trial Estimates of Tolterodine and Fesoterodine Reductions of Urgency Urinary Incontinence Episodes Relative to Placebo
Snedecor, S. J. | 2011
A331
PUK9 Comparative Cost Analysis of Treatment for Renal Anemia with Methoxy Polyethylene-Glycol Erythropoietin Beta (MIRCERA®) Versus Erythropoietin Beta (NEORECORMON®)
Medina G&#x00F3 / mez, J. L. | 2011
A332
PUK14 Trends in Rate and Cost of Hospitalizations Due to Chronic Kidney Disease (CKD) in the United States
Aggarwal, S. | 2011
A333
PHP3 Patient Preferences Considering the Choice of Health Care Providers in Hungary – Results From Discrete Choice Experiment
Baji, P. / Pavlova, M. / Gulacsi, L. / Groot, W. | 2011
A334
PHP9 Temporary Use Authorizations: The Economic and Clinical Future of Drugs Used in the French Compassionate Program
Degrassat-Th&#x00E9 / as, A. / Paubel, P. / Parent de Curzon, O. / Le Pen, C. / Sin&#x00E8 / gre, M. | 2011
A335
PHP14 Multiple Indication Pricing, Reimbursement and Funding Dynamics: The Case of Orphan Indications
Wild, L. / Forster, L. | 2011
A336
PHP21 Adoption of New Medicines in the OECD: Regulation, Innovation and Scale
Varol, N. / Costa-i-Font, J. / Mcguire, A. J. | 2011
A337
PHP26 Health Outcomes and Economics Research for Regenerative Medicine and Cellular Therapies: Lessons From A Multi-Market Health Technology Assessment and Reimbursement review
Faulkner, E. C. / Fernandez, M. / Spinner, D. S. | 2011
A338
PHP31 The Economic Impact of Switches of Prescription Drugs to the Over-the-Counter Status (Rx-to-OTC): A Systematic Literature Review
Karray, S. M. / Plich, A. / Flostrand, S. / Toumi, M. | 2011
A339
PHP37 Regional Drug Evaluation in Spain: A Comparison Among Committees
Hern&#x00E1 / ndez-Pastor, L. J. / Huerta, A. | 2011
A340
PHP42 Drug Consumption in Bosnia and Herzegovina - Comparison to Neighboring Country
Krehic, J. / Gavrankapetanovic, F. / Djapo, M. / Agic, N. | 2011
A341
PHP48 Croatian Pharmaceutical Expenditure Before and After Healthcare Reform – Comparison to EU Countries
Pogorilic, S. / Vitezica, P. / Bolanca, S. | 2011
A342
PHP54 Predictors of Avoidable Emergency Room Visits Among High Cost Medicaid Enrollees
Ganduglia, C. / Franzini, L. / Dunn, K. | 2011
A343
PHP59 Estimation of Increases in Direct Medical Expenditures Associated with Medication Nonadherence and Potential Savings from Increased Adherence
Hicks, K. A. / Karve, S. J. / Vlahiotis, A. / Frazee, S. G. / Tian, Y. / Earnshaw, S. R. | 2011
A344
PHP64 Reorganisation of Hospital Emergency Services: A Business Case for Quality Improvement
Eichler, K. / Senn, O. / R&#x00FC / themann, I. / B&#x00F6 / gli, K. / Sidler, P. / Br&#x00FC / gger, U. | 2011
A345
PHP70 Value Based Pricing (VBP): Is This the Way Forward for the UK NHS?
Comberiati, U. / Dass, R. N. / White, N. | 2011
A346
PHP75 The Cost Per Day of Intensive Care Units (ICU) in France: The CRRÉA Study
Garrigues, B. / Lefrant, J. Y. / Bazin, J. / Bardoulat, I. / Tagdichti, K. / Courtial, F. / Maurel, F. / Pribil, C. | 2011
A347
PHP80 Where A Cheap Medicine is Not the Same as A Generic Medicine: The Belgian Case
Dylst, P. / Vulto, A. / Simoens, S. | 2011
A348
PHP86 Incorporating the Patient Perspective Into the Health Care Process: Experience from the C.A.T. Health System
Rebollo, P. / Castej&#x00F3 / n, N. / Cuervo, J. / Igarreta, M. / Ortega, F. | 2011
A349
PHP92 Lack of Clinical Efficacy as a Main Reason for Ahtapol Negative Recommendations for Orphan Oncology Drugs
Ofierska-Sujkowska, G. / Jagodzinska-Kalinowska, K. / Matusewicz, W. / Pasierski, T. | 2011
A350
PHP97 Use of Paediatric “Observation Status” and Effect on in-Patient Admission Rate in Accident and Emergency (A&E) Departments
Laokri, S. / Zhang, W. H. / Ben Hamed, N. / Cohen, L. / De Wever, A. / Alexander, S. | 2011
A351
PHP103 Global Health Care Reforms and Pricing, Access and Health Outcomes Strategy
Aggarwal, S. | 2011
A352
PHP108 Public Health and Prevention in Europe: Is it Cost-Effective?
Simoens, S. | 2011
A353
PHP113 Measuring the Organizational Performance in Tennessee: A Case of Community Hospitals
Roh, C. Y. / Shirore, R. M. | 2011
A354
PHP119 Is There No Optimal Approach for Orphan Drugs to Patient Access? Rare Disease is Not Rare and Needs to Develop the New Pricing and Reimbursement Solution
Kim, S. / Cho, Y. / Shim, S. / Lee, J. / Kim, W. / Bae, K. | 2011
A355
PHP124 Personalized Decision Making in Cancer Medicine? Systematic Overview of HTA Procedures and Specific Approaches in Ten Countries Across Four Continents
Schwarzer, R. / Rochau, U. / M&#x00FC / hlberger, N. / Jahn, B. / Sroczynski, G. / Schnell-Inderst, P. / Schall, I. / Kallinger, S. / Lackner, M. et al. | 2011
A356
PHP129 Societal Preferences for Health Technology Disinvestment Policy: Views of Scottish Taxpayers – A Qualitative Study
Hislop, J. M. | 2011
A357
PHP134 Comparison of the Knowledge in Standard Treatment Guidelines among Medical Practitioners and Medical Students
Hettihewa, L. M. / Wimalasena, G. / Tharanga, D. | 2011
A359
PHP146 Current Status and Trends in Performance-Based Schemes Between Health Care Payers and Manufacturers
Carlson, J. J. / Gries, K. / Sullivan, S. D. / Garrison, L. | 2011
A360
PHP151 Evidence on the Impact of Managed Entries on Payers, Patients, Manufacturers, and Health Care Workers
Ferrario, A. / Nicod, E. / Kanavos, P. | 2011
A361
PHP157 Using the CEAC for Value Based Pricing: Don'T Change the Goalposts
Roberts, G. | 2011
A363
PHP168 Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption
Jena, A. B. / Philipson, T. J. | 2011
A364
PCV5 Thromboembolisms with Thrombopoietin Receptor Agonists: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Corrales-&#x00C1 / lvarez, I. / Catal&#x00E1 / pez, F. / Mart&#x00ED / n-Serrano, G. / Montero-Corominas, D. / Calvo-rojas, G. | 2011
A366
PCV15 Guidelines Adherence and Hypertension Control in Patients Suffering from Cardiovascular Disease
Ahmad, N. / Hassan, Y. / Tangiisuran, B. / Meng, O. L. / Aziz, N. A. / Saleem, F. / Atif, M. | 2011
A367
PCV19 Prescription of Angiotensin Converting Enzyme Inhibitors and Hypertension Control in Diabetic Hypertensive Patients
Ahmad, N. / Hassan, Y. / Tangiisuran, B. / Meng, O. L. / Aziz, N. A. / Saleem, F. / Atif, M. | 2011
A368
PCV25 Characterising Patients with A First-Time Admission for atrial Fibrillation in the United Kingdom
Jones, J. / Townsend, R. / Jameson, K. / Amber, V. / Evans, L. M. | 2011
A370
PCV37 Parametric Conditional Non-Frailty Model for Recurrent Events in Persons with Type 2 Diabetes in Sweden: The Example of Myocardial Infarction
Ahmad Kiadaliri, A. / Clarke, P. M. / Gerdtham, U. G. / Nilsson, P. / Eliasson, B. / Gudbj&#x00F6 / rnsdottir, S. / Steen carlsson, K. | 2011
A371
PCV42 A Budget Impact analysis to Estimate the Economic Impact of Sevikarhct® for the Treatment of Arterial Hypertension in Spain
Darba, J. / Kaskens, L. / Nilsson, J. / Oberdiek, A. | 2011
A372
PCV47 Analysis of Transient Ischemic Attack-Related Clinical Outcomes, Health Care Utilization and Cost Burden of Patients with Non-Valvular Atrial Fibrillation
Baser, O. / Wang, L. | 2011
A373
PCV53 Cost Study of Caregiving for Patients with Chronic Symptomatic Heart Failure in Spain, Insights from the Inoescaro Study
Marti, B. / Delgado, J. / Oliva, J. / Llano, M. / Pascual, P. / Comin, J. / Grillo, J. J. / Diaz molina, B. / Culebras, J. / Mart&#x00ED et al. | 2011
A376
PCV70 Cost Effectiveness of Ticagrelor in the Treatment of Acute Coronary Syndrome in Germany
Theidel, U. / Asseburg, C. / Giannitsis, E. / Katus, H. | 2011
A377
PCV76 A Cost-Effectiveness Analysis of Clopidogrel in Patients with Non Stable Acute Coronary Syndrome in Greece
Kourlaba, G. / Fragoulakis, V. / Maniadakis, N. | 2011
A378
PCV81 Cost-Effectiveness of Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndrome: Results from the Plato Study: A Canadian Analysis
Mittmann, N. / Chan, B. / Seung, S. J. / Liovas, A. / Cohen, E. | 2011
A379
PCV86 Long-Term Cost-Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndrome (ACS) from A Mexican Public and Private Health Care Perspective Based on Data from the Plato Trial
Garcia-Castillo, A. / De-los-Rios, M. / Polanco, A. C. / Ramirez, M. A. / Nikolic, E. / Mellstr&#x00F6 / m, C. | 2011
A380
PCV91 Cost-Effectiveness of Endovascular Treatment Versus Open Surgery in Patients with Steno-Occlusive Disease of the Femoral Artery
Ramos-Go&#x00F1 / i, J. M. / Mar-Medina, J. / Valc&#x00E1 / rcel-Nazco, C. / Castilla-Rodr&#x00ED / guez, I. | 2011
A382
PCV102 Evaluation of the Measurement Properties of the Antihypertensive Adherence Survey
Hudgens, S. / Lynch, J. / Pasquale, K. / Zacker, C. | 2011
A383
PCV107 Correlation of Physician-Rated Adherence with Therapeutical Outcomes in Antihypertensive Treatment: Pooled Analysis Findings from Six Valsartan Studies Including 15,583 Available Patients
Villa, L. / Abraham, I. / Macdonald, K. / Denhaerynck, K. | 2011
A384
PCV112 A Comparison of European Health Care Systems on Stroke Prevention in Atrial Fibrillation – Interim Results of a Patient Satisfaction Survey
Oberdiek, A. / Sandberg, A. / Franczok, E. | 2011
A386
PCV123 The Participation Decision for Lifestyle Disease Screening
S&#x00F8 / gaard, R. / Lindholt, J. / Gyrd-Hansen, D. | 2011
A387
PCV128 A Real World Evaluation to Describe the Characteristics, Outcomes and Resource Use Associated with Patients Being Managed by a Secondary Care Based Anticoagulation Service
Rose, P. / James, R. / Chapman, O. / Marshall, S. | 2011
A388
PCV134 Concomitant Medciation Use in US Adults on Statin Therapy: Findings from a Multi-Employer Claims Database
Molife, C. / Zhu, Y. / Yu, C. / Mccracken, R. / Zhao, Z. | 2011
A389
PCV139 Epidemiology and Economic Burden of Atrial Fibrilation to the Public Health Care System in Brazil
Nasciben, V. / Piegas, L. S. / Figueiredo, M. J. / Martins, S. C. | 2011
A391
PGI2 The Relationship Between Acute and Chronic Acetaminophen Exposure and Liver Toxicity
Gokhale, M. N. / Foster, H. R. / Cleves, M. / Hogan, W. R. / James, L. P. / Martin, B. | 2011
A392
PGI7 Impact of Complications from Dysphagia on Hospital Charges in the United States
Jensen, I. S. / Helm, T. / Cyr, P. L. | 2011
A393
PGI13 Evaluation of the Clinical and Economic Burden of Chronic Constipation in Belgium
Leeuwenkamp, O. / Chevalier, P. / Lamotte, M. | 2011
A394
PGI18 Treatment of Chronic Hepatitis C Patients with Peginterferon Alfa-2a or Peginterferon Alfa-2b: A Cost-Effectiveness Analysis for the Portuguese NHS Setting
Areias, J. / Branco, T. / Calinas, F. / Carvalho, A. / Macedo, G. / Manata, M. J. / Matos, L. / Rodrigues, B. / Velosa, J. / Pereira, C. | 2011
A395
PGI23 Economic Impact of Medication Adherence and Persistence in the Treatment of Ulcerative Colitis in Canada: Analyses with the Ramq Database
Lachaine, J. / Yen, L. / Beauchemin, C. / Hodgkins, P. | 2011
A396
PGI28 Disease-Specific Health-related Quality of Life in Patients with Quiescent Ulcerative Colitis: Effects of one Year Maintenance Treatment with MMX Mesalamine
Solomon, D. / Yarlas, A. / Yen, L. / Hodgkins, P. / Karlstadt, R. / Kane, S. V. | 2011
A397
PGI33 Predictors of Direct Medical Costs of Crohn'S Disease and Ulcerative Colitis
Stark, R. G. / Hunger, M. F. / Reitmeir, P. / K&#x00F6 / nig, H. H. / Leidl, R. | 2011
A398
PIH5 Respiratory Syncytial Virus (RSV) Prophylaxis in Special Populations
Paes, B. A. / Li, A. / Lanctot, K. L. / Mitchell, I. | 2011
A399
PIH12 Patients with BPH in France: Results at Six Months with Phytotherapy Versus Other Treatments
Perrin, P. / Auges, M. / Rahhali, N. / Taieb, C. | 2011
A400
PIH18 Rotavirus Gastroenteritis in Vulnerable Children: A UK Case Control Study
Pockett, R. D. / Campbell, D. / Adlard, N. E. / Rajoriya, F. / Carroll, S. M. | 2011
A401
PIH23 Cost-Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Psychostimulant Compared to Psychostimulant Monotherapy for the Treatment of Attention Deficit/Hyperactivity Disorder in Children and Adolescents
Sikirica, V. / Erder, M. / Xie, J. / Macaulay, D. / Diener, M. / Hodgkins, P. / Wu, E. Q. | 2011
A402
PIH28 Economic Evaluation of Pneumococcal Conjugated Vaccines for Argentina
Ellis, A. / Lepetic, A. C. / Gomez, J. A. | 2011
A403
PIH34 Patient Reported Reasons for Medication Nonadherence: A Survey
Lee, K. / Nixon, M. / Cascade, E. / Plummer, C. / Law, V. / Lee, M. | 2011
A405
PIH45 Burden of Herpes Zoster and Post-Herpetic Neuralgia: Findings from a Cross-Sectional Patient Reported Outcomes Study
Carroll, S. / Gater, A. / Abetz, L. / Demuth, D. / Smith, F. / Mannan, A. | 2011
A406
PIH50 quality of Life of Students from the Faculty of Pharmacy at Medical University of Warsaw in 2011
Zawodnik, S. / Kiljan, A. / Hermanowski, T. / Golicki, D. | 2011
A408
PIH62 Comparative Pricing and Reimbursement Analysis in Four East European Countries
Peev, S. / Petrova, G. / Baran, A. / Petrikova, A. / Daneasa, D. | 2011
A409
PIH67 Successful Development of Annual and Long Term Prediction Models to Estimate Height Outcome following Growth Hormone (GH) Therapy in Children Using Data from KIGS – A Large Pharmacoepidemiological Survey
Loftus, J. / Ranke, M. / Lindberg, A. / Brosz, M. / Kaspers, S. / Wollmann, H. / Koltowska-Haggstrom, M. / Roelants, M. | 2011
A410
PSY4 Comparison of Infliximab and Ustekimumab for Treatment of Moderate to Severe Psoriasis: a Mixed Treatment Meta-Analysis
Fan, T. / Bennett, H. / Smith, N. / Marin, M. / Sen, S. | 2011
A412
PSY15 Striving for Affordable Treatments Within the Greek Environment: Do Epoetin Biosimilars Help?
Kani, C. / Litsa, P. / Alexopoulou, E. / Hatzikou, M. / Delibasi, S. / Geitona, M. | 2011
A413
PSY20 The Annual Direct Medical Cost of Systemic Lupus Erythematosus (Sle) Patients and Costs Drivers (Lucie Study): French Results
Amoura, Z. / Pennaforte, J. L. / Hamidou, M. / Arfi, S. / Lazaro, E. / Hachulla, E. / Pourrat, J. / Queyrel, V. / Aubin, C. / Garofano, A. | 2011
A414
PSY25 What is the Economic Impact of Obesity on Hospital Inpatient Care?
Pereira, J. / Ribeiro, V. / Mateus, C. | 2011
A415
PSY31 Cost-Effectiveness of Tapentadol Prolonged-Release (Pr) Compared to Oxycodone Controlled Release (Cr) in Patients with Chronic Severe Non-Cancer Pain in Ireland
Obradovic, M. / Ikenberg, R. / Hertel, N. / Liedgens, H. | 2011
A416
PSY36 Modelling the Cost-Effectiveness of Orlistat as a Treatment for Obesity in Primary Care
Ara, R. / Blake, L. | 2011
A417
PSY42 Chronic Pain: Patient Treatment Preferences - a Discrete Choice Experiment
M&#x00FC / hlbacher, A. / Ezernieks, J. / N&#x00FC / bling, M. | 2011
A418
PSY47 Evaluating the Cross-over Effect on Health-related Quality of Life in a Randomized Cross-over Study of Hemophilia-A Patients
Jo, H. / Gringeri, A. / Leissinger, C. / Mantovani, L. / Cortesi, P. / Gemmen, E. | 2011
A419
PSY53 Changes in Concomitant therapy for Weight-related Illness Following Initiation of Weight Loss Pharmacotherapy
Agatep, B. C. / Charland, S. L. / Herrera, V. / Hawk, G. / Stanek, E. J. | 2011
A420
PSY58 Responsiveness of the Treatment Satisfaction with Medicines Questionnaire (Satmed-Q) in a Longitudinal Sample of Patients with Neuropathic Pain
Rejas, J. / Ruiz, M. A. / Pardo, A. / Ruiz, L. / Soto, J. | 2011
A421
PRM5 Novel Patient Reported Outcomes and Data Tool for Chronic Disease Management (PROCDIM): Case in Point Prostate Cancer
Aggarwal, S. | 2011
A422
PRM11 Learning Effect in Economic Evaluations of Health Care Interventions
Chang, S. / Sungher, D. / Diamantopoulos, A. | 2011
A423
PRM17 Suitability of CLAD-CQR Models for Obtaining QALYs
Cunillera, O. / Vilagut, G. / Medina, A. / Tresserra, R. / Alonso, J. / Brugulat, P. / Garc&#x00ED / a, C. / Ferrer, M. | 2011
A424
PRM22 Microsimulation Methods Used for Health Policy Decisions in Personalized Medicine Under Constrained Resources
Jahn, B. / Rochau, U. / M&#x00FC / hlberger, N. / Sroczynski, G. / Conrads-Frank, A. / Siebert, U. | 2011
A425
PRM27 Modelling the Brazilian Extended Consumer Price Index for Pharmaceutical Products: Comparison Between Exponential Smoothing and Box-Jenkins Methods
Santos, P. M. / Takemoto, M. L. / Fernandes, R. A. / Tolentino, A. C. / Takemoto, M. M. / Fernandes, R. R. / Padula, A. C. / Cukier, F. N. / Cruz, R. B. | 2011
A426
PRM33 Systematic Review of Health State Utilities in Spain
Garc&#x00ED / a-P&#x00E9 / rez, L. / Aguiar-Ib&#x00E1 / ez, R. / Linertov&#x00E1 / R. / Rivero-Santana, A. / Ab&#x00E1 / solo-Aless&#x00F3 et al. | 2011
A428
PRM44 The First Research: Assessment of the WTP Threshold for QALY by Contingent Valuation Method in Russia
Zelenova, O. | 2011
A429
PRM49 Evaluation of Bivariate Meta-analysis Methods to Synthesise Results of Several Studies with Two Correlated Endpoints
Aballea, S. / Vataire, A. L. / Neine, M. E. / Le coroller, G. / Toumi, M. | 2011
A430
PRM55 A New Approach to Modeling Cancer Recurrence and Follow-Up
Rose, J. / Augestad, K. M. / Cooper, G. / Meropol, N. J. | 2011
A431
PRM60 Assessing Relative Clinical Value Across Tumor Types in Metastatic Disease
Karweit, J. / Nanavati, S. / Van Baardewijk, M. / Wagner, S. / Kotapati, S. | 2011
A432
PRM66 Comparison of Reconciliation and Review Methodologies for the Translation of Patient Reported Outcome (PRO) Measures
Verjee-Lorenz, A. / Two, R. / Clayson, D. / Miller, F. | 2011
A433
PCN3 Cetuximab for the First-Line Treatment of Metastatic Colorectal Cancer
Ubago, R. / Castillo, M. A. / Flores, S. / Rodriguez, R. / Beltran, C. | 2011
A434
PCN8 Incidence, Predictive Factors, and Infection Complications of Prolonged Neutropenia in R-CHOP/CHOP Treated Diffuse Large B-Cell Lymphoma Patients
Zhou, K. R. / Kei, K. M. / Ng, H. M. / Wong, R. S. | 2011
A435
PCN12 Dasatinib or Imatinib in Newly Diagnosed Chronic Myeloid Leukemia Patientes in the Chronic Phase: Five-Years Follow-up Simulated Cohort
Darba, J. / Perez-Alvarez, N. / Kaskens, L. / Martin, P. | 2011
A437
PCN23 Survival Analyses Adjusted for Crossover in Relapsed Multiple Myeloma: Results of the Apex Trial
Pacou, M. / Gauthier, A. / Abrams, K. / Spencer, M. | 2011
A438
PCN29 Budgetary Impact of Adoption of Erlotinib for Lung Cancer in the Private Health Insurance Market in Brazil: A Real World Data Analysis
Clark, O. / Clark, L. G. / Botrel, T. E. / Medina, P. / Paladini, L. / Rosa, B. / Rodrigues, N. / Fortes, A. F. / Castro, A. P. / Faleiros, E. | 2011
A439
PCN34 Cost Analysis of Anemia Treatment with Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in Italy
Duran, A. / Spaepen, E. / Lamotte, M. / Lucioni, C. / Kutikova, L. / Pujol, B. / Gozzo, M. / Annemans, L. | 2011
A440
PCN39 Burden of Brain Metastasis in an Metastatic Non-Small Cell Lung Cancer (NSCLC) Population
Ganguli, A. / Henk, H. / Teitelbaum, A. / Ray, S. | 2011
A442
PCN50 First and Second Line Lung Cancer Treatment Utilization Patterns and associated Costs in A United States Health Care Claims Database
Ramsey, S. / Henk, H. / Sullivan, J. / Teitelbaum, A. / Akhras, K. / Sollano, J. / Smith, G. / Chen, C. | 2011
A443
PCN55 The Economic Burden of Adjuvant Chemotherapy in Germany
Eiermann, W. / Rezai, M. / Kuemmel, S. / K&#x00FC / hn, T. / Benkow, A. / Hogberg, D. / Schweikert, B. / Blohmer, J. U. | 2011
A444
PCN60 Economic Evaluation of Vaccination Against Cervical Cancer in the Moscow Region
Shakhanina, I. / Namazova-baranova, L. / Krasnopolskiy, V. I. / Zarochentseva, N. V. / Kozachenko, V. P. / Demarteau, N. / Shchurov, D. | 2011
A445
PCN65 Cost-Effectiveness of Treating Metastatic Renal Cell Carcinoma (mRCC) Patients Whose Disease Failed on one Prior VEGF-TKI Therapy with Everolimus Compared to Treating with Best Supportive Care (BSC) Alone in Canada
Casciano, R. / Chulikavit, M. / El Ouagari, K. / Wang, X. | 2011
A446
PCN70 Cost-Effectiveness of Cetuximab and Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer (mCRC) for Patients with Kras Wild-Type Tumours in the United Kingdom
Samyshkin, Y. / Hertel, N. / Griebsch, I. | 2011
A447
PCN75 Epidemiologic and Economic Impact of HPV (6/11/16/18) Vaccination in Turkey
Bakir, M. / Levent, A. / Nagy, L. / Brandtm&#x00FC / ller, A. / Singhal, P. / Pillsbury, M. / Dasbach, E. | 2011
A448
PCN80 Comparative Analysis of Cost-Effectiveness Bevacizumab + Paclitaxel Versus Using Only Versus Paclitaxel as First Line Treatment of Patients with Metastatic Breast Cancer in Mexico Public Insurance (Seguro Popular)
Arreola Ornelas, H. / Rosado Buzzo, A. / Garc&#x00ED / a, L. / Camacho, L. M. / Lechuga, D. | 2011
A449
PCN86 Cost-Effectiveness of Rituximab in Follicular Lymphoma First Line Maintenance Treatment from Public Payer Perspective in Poland
Gadaj, A. / Kalinowska, A. / Hawrylecka, D. / Holojda, J. / Krawcewicz, A. / Spychalowicz, W. / Russel-Szymczyk, M. / Szkultecka-debek, M. | 2011
A450
PCN91 Pharmacoeconomic Analysis of mCRC Therapy With XELOX/FOLFOX4 Regimes With Bevacizumab or Cetuximab as the First Line Treatment in Russia
Tikhomirova, A. V. / Yagudina, R. I. / Kulikov, A. U. | 2011
A452
PCN102 Economic Evaluation of Three Formulations of Leuprolide Acetate With Atrigel® in Androgen Deprivation Therapy for Advanced Prostate Cancer in Nine European Countries
Retsa, P. / Sidhu, M. / Odeyemi, I. / Tombal, B. / Wex, J. | 2011
A453
PCN107 Potential Benefits of Introducing A Companion Diagnostic in Advanced Non-Small Cell Lung Cancer
Zaim, R. / Gaultney, J. / Redekop, W. / Uyl-de Groot, C. | 2011
A455
PCN117 Health Resource Utilisation (HRU) Associated with Skeletal-Related Events (SREs) in Patients with Bone Metastases (BMS): Results From a Retrospective, Multinational European Study
Gunther, O. / Body, J. J. / Sleeboom, H. / Hechmati, G. / Pereira, J. / Maniadakis, N. / Terpos, E. / Acklin, Y. P. / Finek, J. / Mossman, T. | 2011
A456
PCN122 Disclosing Traditional & Complementary Medicines (T&CM) Use to the Health Care Providers: A Qualitative Study Among Cancer Patients at a Local Hospital in Malaysia
Farooqui, M. / Hassali, A. / Knight, A. / Akmal, A. / Tan, B. S. / Farooqui, M. A. | 2011
A457
PCN128 EQ-5D Utility Index in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) With Progression During or After First-Line Docetaxel Therapy
James, N. / Eisenberger, M. / Fizazi, K. / Heidenreich, A. / Joulain, F. / Laizet, C. | 2011
A458
PCN133 Measuring Patients' Expectation and Satisfaction With Integrative Cancer Therapy
An, S. M. / Kim, S. H. / Kim, K. S. / Chung, H. S. / Lee, S. K. / Cheon, S. / Lee, S. H. / Park, S. / Kim, E. H. / Eo, W. K. | 2011
A459
PCN138 The Impact of Advanced or Metastasic Non-Small Cell Lung Cancer (NSCLC) Symptoms on Patient Daily Living and Health Related Quality of Life: Final Results
Artal, A. / Oramas, J. / Cobo, M. / Domine, M. / Barneto, I. / Rodr&#x00ED / guez-Abreu, D. / Menendez-ure&#x00F1 / a, M. / Andrade, J. et al. | 2011
A461
PCN148 Estimating Quality of Life in Advanced Melanoma; A Comparison of Standard Gamble, SF-36 Mapped, and Eortc QLQ-C30 Mapped Utilities
Batty, A. J. / Fisher, D. / Winn, B. / Wang, Q. / Tolley, K. / Rowen, D. | 2011
A462
PCN154 Discussing the Introduction of National Screening Programs in Greece: A Delphi Study
Skroumpelos, A. / Pavi, E. / Kyriopoulos, J. | 2011
A463
PCN159 Diagnostics and Treatment of Patients with Non-Small-Cell Lung Cancer in Daily Practice
Blommestein, H. / Groen, H. / Smit, E. / Thunnissen, E. / Uyl-de Groot, C. | 2011
A464
PCN165 A First Estimate of the Incremental Impact of Males HPV Vaccination on HPV-Related Diseases in Europe
Bresse, X. / Largeron, N. / Marty, R. / Roze, S. | 2011
A465
PCN171 Underlying Causes for Sub-Optimal Utilisation of Cancer Drugs Funds in England
Viejo Viejo, I. / Kilby, S. | 2011
A466
PCN177 Assessment of Reimbursement Processes and Outcomes for Cancer Drugs in Croatia – Comparison to NICE and NCCN Guidelines
Vitezic, D. / Vrdoljak, E. / Bolanca, S. | 2011
A467
PCN183 A Population-Based Registry for the Evaluation of New Treatment Options for Patients with Metastatic Renal Cell Carcinoma
De groot, S. / Redekop, W. / Kiemeney, L. / Uyl-de Groot, C. | 2011
A468
PCN188 Did Decision-Making Models from National Guidelines Change 1st Line Treatment Strategy for Patients with Metastatic Colorectal Cancer (MCRC)? The Results of Large Population Based Survey in Germany 2009
Kellermann, L. / Hofheinz, R. D. / Arnold, D. | 2011
A469
PCN193 Using Whole Disease Modelling to Inform Economic Recommendations for the Detection, Diagnosis, Treatment and Follow-up of Colorectal Cancer
Tappenden, P. / Brennan, A. / Chilcott, J. / Squires, H. | 2011
A471
PDB2 Considerably Increasing Incidence of Severe Hypoglycemia 2007-2010 Versus 1997-2000 – a German Longitudinal Population-Based Study
Holstein, A. / Patzer, O. M. / Machalke, K. / Holstein, J. D. / Dippel, F. W. / Kovacs, P. | 2011
A472
PDB8 A Network Meta Analysis to Compare Glycaemic Control in Patients with Type 2 Diabetes Treated with Exenatide Once Weekly or Liraglutide
Scott, D. / Boye, K. S. / Timlin, L. / Best, J. H. / Clark, J. | 2011
A473
PDB13 A Prospective Registry to Identify Patients' Characteristics Associated with Achieving Target Metabolic Control After Three Months Treatment with Insulin Glulisine in Type 1 And 2 Diabetes Mellitus Patients Previously Uncontrolled on Basal Insulin and/or Other Anti-Diabetic Treatment (API Registry)
Gottesman, I. / Girard, M. / Shorey, S. | 2011
A474
PDB18 Australia: Management of the Diabetic Foot with Pedimed® Under Real Use Conditions
Taieb, C. / Auges, M. | 2011
A475
PDB24 Budget Impact Analysis of the Use of Aspart Insulin During Hospitalization of Patients with Hyperglycaemia in Italy
Iannazzo, S. / Pradelli, L. / Montagnoli, R. / Militano, L. | 2011
A476
PDB29 Modeling the Impact of Enhanced Treatment of Type 2 Diabetes Mellitus in Bulgaria
Boyanov, M. / Petrova, G. / Henriksen, O. / Valov, V. | 2011
A477
PDB35 Estimating the Real Life Daily Usage and Daily Cost of GLP-1 Receptor Agonists in the UK Setting
McDonell, A. / Zammit, D. C. / Haslam, T. / Gregor, Z. / Wilson, B. P. | 2011
A478
PDB40 Economic Analysis of Diabetes Treatment Goals Defined by Polish Diabetes Association: How Much Does Cost-Effective Treatment Cost?
Szmurlo, D. / Schubert, A. / Kostrzewska, K. / Rys, P. / Skrzekowska-Baran, I. | 2011
A479
PDB45 Cost-Effectiveness of Transferring Type 2 Diabetic Patients from Neutral Protamine Hagedorn (NPH) to Detemir in Portugal Settings
Carvalho, D. / Lindner, L. / Kozarzewski, M. | 2011
A480
PDB50 Reduction in Comorbidities and Cost Savings Associated with Biochemical Control in Patients with Cushing's Disease: A Literature-Based Analysis
Patel, D. / Stephens, J. M. / Wiegand, P. / Pulgar, S. | 2011
A482
PDB61 Assessment of Quality of Life in Children and Adolescents with Type 1 Diabetes Mellitus
Moreira, S. / Almeida, A. / Guerra, P. | 2011
A483
PDB66 Achievement of Glycemic Control and Relapse Among Patients Initiating Basal Insulin from a Geographically-Diverse Us Electronic Medical Record (EMR) Database
Aargen, M. / Wu, N. / Boulanger, L. / Lamothe, K. | 2011
A484
PDB71 Cross-Sectional Analysis of Ambulatory Care Expenditure Among Patients with Type 2 Diabetes Mellitus (T2DM) According to Treatment Stage and Renal Function in France Using EGB Database (Echantillon Generaliste De Beneficiaires)
Guelfucci, F. / Clay, E. / Aballea, S. / Toumi, M. / Lassalle, R. | 2011
A485
PDB77 Impact of Knowledge on Medication Adherence Among Type 2 Diabetes Patients
Al-Qazaz, H. K. / Syed Sulaiman, S. A. / Hassali, M. A. / Shafie, A. A. / Sundram, S. / Saleem, F. | 2011
A486
PDB82 Development of a Health Economic Model to Compare the Prevention, Treatment and Management Strategies of Type 2 Diabetes
Nagy, B. / Nagyjanosi, L. / Nagyistok, S. / J&#x00F3 / zwiak-Hagym&#x00E1 / sy, J. / Dessewffy, Z. / Kalo, Z. / Vok&#x00F3 / Z. | 2011
A487
PRS4 Effectiveness Of a Multifactorial Intervention to Improve Adherence in Patients with Chronic Obstructive Pulmonary Disease (COPD) Icepoc Study
Leiva-Fernandez, F. / Barnestein-Fonseca, P. / Leiva- Fernandez, J. / Vidal-Espa&#x00F1 / a, F. / Garc&#x00ED / a-Ruiz, A. / Prados-Torres, D. | 2011
A488
PRS10 A Comparative Health Economic Evaluation of Two Treatments for Grass Pollen Induced Allergic Rhinoconjunctivitis
Ronborg, S. M. / Svendsen, U. G. / Micheelsen, J. S. / Ytte, L. / Andreasen, J. N. / Ehlers, L. | 2011
A489
PRS15 Estimating the Budget Impact of Introducing Indacaterol in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) from the Brazilian Public Health Care System (SUS) Perspective
Suzuki, C. / Silva, N. L. | 2011
A490
PRS20 Costs of COPD By Disease Severity - a Comparison Over 10 Years
Jansson, S. A. / Backman, H. / Lindberg, A. / R&#x00F6 / nmark, E. / Lundb&#x00E4 / ck, B. | 2011
A492
PRS30 Identifying the Patient Population Where Treatment of Severe Allergic Asthma with Omalizumab (XOLAIR®) Exhibits Optimal Cost-Effectiveness in Australia
Tilden, D. / Cottrell, S. / Tocchini, L. / Frenzel, C. / Bonney, M. A. | 2011
A493
PRS36 The Cost-Effectiveness of Step Down from High Dose ICS/Laba Combination Therapy in Asthma in the UK Setting
Paggiaro, P. / Buseghin, G. / Nicolini, G. / Patel, S. / Iannazzo, S. / Zaniolo, O. / Papi, A. | 2011
A494
PRS41 Cost-Effectiveness Analysis of Immunotherapy in Patients with Grass Pollen Allergic Rhinitis
Westerhout, K. Y. / Verheggen, B. G. / Schreder, C. H. / Sieber, J. / Augustin, M. | 2011
A495
PRS46 Effectiveness and Cost-Utility Estimates of Tiotropium Treatment and Pulmonary Rehabilitation Programs in French Patients with Chronic Obstructive Pulomonary Disease
Atsou, K. / Hejblum, G. / Chouaid, C. | 2011
A496
PRS51 The Development of the Early Morning Symptoms of COPD Instrument (EMSCI)
Palsgrove, A. / Houghton, K. / Hareendran, A. / Schaefer, M. / Setyawan, J. / Mocarski, M. / Carson, R. / Make, B. | 2011
A497
PRS56 Assessing Patient Report of Function: Content Validity of the Functional Performance Inventory-Short form (FPI-SF) in Patients with Chronic Obstructive Pulmonary Disease
Leidy, N. / McCormack, J. / Hamilton, A. / Becker, K. | 2011
A498
PRS62 Comparison of Generic and Disease Specific Quality of Life Measures in Chronic Obstructive Pulmonary Disease
Agh, T. / Inotai, A. / Meszaros, A. | 2011
A499
PRS67 Consumption Patterns and in Vitro Resistance of S. Pneumoniae to Fluoroquinolones
Simoens, S. / Verhaegen, J. / Van Bleyenbergh, P. / Peetermans, W. / Decramer, M. | 2011
A500
PRS72 How Much Would the Universal Uptake of Gold Recommendations for Italian COPD Patients Cost?
Zaniolo, O. / Bettoncelli, G. / Bosio, G. / Mantovani, L. G. / Pistelli, R. / Vaghi, A. / Villa, M. / Iannazzo, S. / Bamfi, F. / Pitrelli, A. | 2011
A501
PRS77 Application of Innovative Methods to Identify and Characterize Differential Responders in Clinical Trials of COPD: The Use of Mixture Models
Stull, D. E. / Houghton, K. / Gale, R. / Wiklund, I. / Capkun-Niggli, G. / Jones, P. | 2011
A502
PSS5 Visual Field Evolution in Glaucoma Patients Presenting With Different Disease Stages: Results From an Observational Study
Gerlier, L. / Shlaen, R. / Wolfram, C. / Lamotte, M. / Verboven, Y. | 2011
A503
PSS11 Ranibizumab and Bevacizumab for the Treatment of Age-related Macular Degeneration: A Systematic Review and Economic Evaluation
Martinez Ferez, I. M. / Flores Moreno, S. | 2011
A504
PSS16 Cost of Blindness in Austria
Brennig, C. / Sch&#x00F6 / llbauer, V. / Walter, E. | 2011
A505
PSS22 A Cost-Effectiveness Analysis of Off-Label Biologics to Treat Sarcoid Posterior Uveitis Versus Standard of Care: Comparing Infliximab to Methotrexate and Systemic Steroids
Padula, W. V. / Yilmaz, T. / Cordero-Coma, M. | 2011
A506
PSS27 We Treat Eyes, Not People: The Systematic Overestimations of Utility in Age-Related Macular Degeneration Models
Visser, M. S. / Amarakoon, S. / Missotten, T. / Busschbach, J. | 2011
A507
PSS32 Impact of Dry Eye on Everyday Life (Ideel) - Symptom Bother: Estimating Cut-off Scores for Dry Eye Severity Groups
Acaster, S. / Verboven, Y. / Begley, C. / Chalmers, R. / Abetz, L. / Thompson, T. | 2011
A508
PSS37 the Clinical and Economic Burden of Acute Otitis Media: A Large Prospective Observational Cohort Study in Europe
Liese, J. G. / Giaquinto, C. / Silfverdal, S. A. / Carmona, A. / Larcombe, J. / Garcia-Sicilia, J. / Fuat, A. / Mu&#x00F1 / oz Hiraldo, E. / Arroba Basanta, M. L. et al. | 2011
A509
PSS42 Evaluation of the Impact of Writing Exercises and Educational Interventions on Quality of Life in Patients With Psoriasis
Tabolli, S. / Pagliarello, C. / Sampogna, F. / Di Pietro, C. / Abeni, D. / Centro Studi GISED, I. | 2011
A511
ISPOR 14th annual European congress financial disclosure information for research presetnations
| 2011
A521
ISPOR 14th Annual European Congress Research Abstracts Author Index
| 2011
A535
EX2 Health Care Resource Use Among Patients With Bipolar Disorder From Brazil and Venezuela: Subgroup Analysis of Data From A Large Multinational Longitudinal Study (WAVE-BD Study)
Vieta, E. / Baptista, T. / Bifano, M. / Kerr-Corr&#x00EA / a, F. / Grohs, G. / de Oliveira, I. / Vielma, X. / Montes, C. / Beluche, S. | 2011
A536
QA3 Costo-Efectividad De Dabigatran Versus Warfarina En El Manejo De La Fibrilacion Auricular En Colombia
Alfonso-Cristancho, R. / Herran, S. / Caicedo, M. / Gomez, E. | 2011
A537
VA1 Evaluacion Rápida Del Impacto De La Introduccion De La Vacuna Contra El Rotavirus En Colombia
Rico Mendoza, F. A. / Porras, A. / Alvis, N. / De La Hoz, F. / Cediel, N. / Del Rio, F. | 2011
A538
CN2 Cancer De Pulmon Y Tabaco, Analisis Del Costo De Atencion Medica
Quintana Carrillo, R. / Arrieta Rodr&#x00ED / guez, O. / Zinser Sierra, J. / Correa Acevedo, M. / Mohar Betancurt, A. / Reynales Shigematsu, L. | 2011
A539
HS3 The Economic Burden of Road Traffic Injuries on Health System and Society in Belize
Heredia Pi, I. B. / P&#x00E9 / rez N&#x00FA / ez, R. / Hijar Medina, M. / Jones, S. / Silveira Rodrigues, E. M. | 2011
A540
IN4 Morbidity and Mortality of Community Acquired Pneumonia in Adults in Six Countries in Latin America
Rosado-Buzzo, A. / Garcia-Mollinedo, L. / Camacho-Cordero, L. / Roberts, C. S. / Mould-Quevedo, J. F. / Trejo-Martinez, A. / Luna-Casas, G. | 2011
A541
RM2 Aplicacion de Modelos De Regresion Con Stata Para El Estudio Del Consumo de Recursos En Unidades De Cuidados Intensivos Neonatales
Reyes-Lopez, A. | 2011
A542
PCN3 Estimacion De La Carga De Los Tumores Neuroendocrinos En Colombia
Ruiz, A. / Alfonso-Cristancho, R. / Mejia, A. / Gonzalez, D. / Maestre, K. / Herran, S. | 2011
A543
PCN8 Cost-Effectiveness Analysis of an Opioid in Combination with Gabapentin Versus Monotherapy for the Treatment of Neuropathic Pain
Galindo, L. / Guajardo, J. / Plancarte, R. / Cerezo, O. / Najera, E. / Gonzalez, I. | 2011
A544
PCV4 Analisis Costo Efectividad En El Largo Plazo De Los Stents Liberadores De Farmaco vs Stents Convencionales En Pacientes Con Cardiopatia Isquemica En El Imss
Gonzalez-Diaz, B. E. / Salinas Escudero, G. / Granados-Garcia, V. / Hern&#x00E1 / ndez, I. C. / Abbo, M. C. | 2011
A545
PCV9 Costo–efectividad De Los Ácidos Grasos Omega 3 Como Coadyuvante De La Simvastatina En El Tratamiento De La Hipertrigliceridemia
Rendon, D. / Ordo&#x00F1 / ez, J. / Orozco, J. J. | 2011
A546
PDB5 Use of a Discrete Event Simulation Model to Estimate Clinical and Economic Outcomes of Various Self-Monitoring of Blood Glucose Regimes Plus Conventional Pharmacologic Treatment on Type-2 Diabetic Patients in Mexico
Zanela, O. O. / Cabra, H. A. / Mu&#x00F1 / oz, D. F. | 2011
A547
PDB10 Economic Evaluation of Duloxetine as First-Line Treatment for Painful Diabetic peripheral Neuropathy in Mexico
Carlos, F. / Ram&#x00ED / rez-G&#x00E1 / mez, J. / Due&#x00F1 / as-Tentori, H. / Ramos, E. | 2011
A548
PGI4 Health-Related Quality of Life Improvements in Patients with Active Crohn's Disease Following Treatment with Certolizumab Pegol in the Music Study (NCT00297648)
H&#x00E9 / buterne, X. / L&#x00E9 / mann, M. / Coteur, G. / Ernault, E. / Colombel, J. F. | 2011
A549
PHP6 Cuadro Básico Y CatÁlogo De Medicamentos Del Sector Salud: Es Actualmente Un referente Para Las instituciones PÚblicas Y/O cumple Con Los Objetivos De Su Creación
Rivera-Pe&#x00F1 / a, G. / Vargas-Palacios, A. / Barraza-Llorens, M. / Gutierrez-Delgado, C. | 2011
A551
PHP18 Impacto De La Participacion Del Farmaceutico Como Parte Del Equipo De Salud En El Primer Nivel De atencion sobre Los Costos
Mino-Leon, D. / Contreras-Hernandez, I. / Anaya, P. / Reyes, A. | 2011
A552
PHP24 ComparaÇÃo Da qualidade De Vida Entre Pessoas Com DoenÇas Crónicas E Pessoas Da Comunidade Sem DoenÇa
Pais-Ribeiro, J. / Silva, I. / Pedro, L. / Meneses, R. / Cardoso, H. / Abreu, M. / Melo, V. / Martins, A. / Martins-da Silva, A. / Vilhena, E. | 2011
A553
PHP29 Predictors of Appropriate Use of Insecticide Treated Nets in an Urban Community: The Case of Asokwa Sub-Metropolitan Area, Kumasi, Ashanti, Ghana
Agyei-Baffour, P. / Mantey, K. G. / Owusu-Dabo, E. | 2011
A554
PHP36 Historical and Future Drivers for HTA in Reimbursement Systems in Mexico and Poland
Kirpekar, S. / Shankland, B. | 2011
A555
PHP41 Monitoring of HPV Vaccination Effectiveness Within European Union
Bielik, J. / Maru&#x0161 / kov&#x00E1 / E. / Glogowski, C. | 2011
A556
PHP47 AvaliaÇÃo Do Mercado De Antimicrobianos No Brasil: Passo Para ImplantaÇÃo Do Monitoramento E Controle SanitÁrio Em Estabelecimentos FarmacÊuticos
Mota, D. M. / Ara&#x00FA / jo, M. A. / Santos, A. E. / Cunha, T. R. / Silva, S. F. / Bovi, R. F. / Alaver, R. T. / Albo, G. C. / Cunha, J. A. et al. | 2011
A558
PIN2 Facing Critical Health Events: Economic Impact Of AH1N1 Flu Epidemic In The Mexican Health Sector, 2009-2010
Gutierrez-Delgado, C. / G&#x00F3 / mez-Fraga, S. | 2011
A559
PIN8 Evaluacion Economica De La Extension De Profilaxis Contra CMV De 100 A 200 Dias En Receptores De Trasplante Renal Con Alto Riesgo (D+ / R−)
Morales Buenrostro, L. E. | 2011
A560
PMH2 The COST-Effectiveness Of Paliperidone Palmitate Compared To Olanzapine Pamoate In The Treatment Of Schizophrenia In Sweden
Pudas, H. / Hemels, M. / Mehnert, A. / Druais, S. / Martin, M. | 2011
A561
PMS3 Impacto Economico De La Osteoporosis Y De Las Fracturas Por Fragilidad En El instituto Mexicano Del Seguro social
Clark, P. / Carlos, F. / Chico, G. / Galindo-Suarez, R. M. | 2011
A562
PMS8 Cost-Effectiveness analysis of Etanercept versus Available anti-Tnf and Il-6 Blockers for Treating Rheumatoid Arthritis in Guatemala
Lutz, M. / Cuesta, G. / Morales, G. | 2011
A563
PMS13 Economic Model of Workplace Impacts of anti-Tnf therapy for Rheumatoid Arthritis in Brazil
Teich, V. / Chaves, L. / Birnbaum, H. / Pike, C. / Waryas, C. / Cifaldi, M. | 2011
A565
PRS4 Economic Evaluation of the Use of Palivizumab as prophylactic Treatment for the reduction of Complications associated with respiratory Syncytial Virus in Pre-Term Patients
Mayen-Herrera, E. / Buesch, K. / Cortina, D. | 2011
A566
PRS9 Disponibilidad A Pagar Por Un Metodo Efectivo Para Dejar De Fumar: Evidencias A Partir De La Encuesta Global De Tabaquismo En Adultos MÉxico 2009
Heredia, I. / Serv&#x00E1 / n, E. / Reynales, L. M. / Bautista, S. | 2011
A567
PSY2 ESTIMACIÓn Del Impacto Financiero En La Salud De La POBLACIÓn Mexicana Derivado De La Obesidad Y El Sobrepeso, 2000-2017
Guajardo-Barron, V. J. / Gutierrez-Delgado, M. C. | 2011
A568
PSY7 Cost Of Managing Bleeding-Related Episodes (BRE) For Romiplostim Versus Standard Of Care (SOC) In Patients With Chronic Immune Thrombocytopenia (ITP) In Mexico
Arocho, R. / Northridge, K. / Rivera Hurtado, R. / Chavez, J. G. | 2011
A569
PUK1 Comparison Of Direct Medical Cost Of Dialysis In A Mexican Cohort Either On Peritoneal Or Hemodialysis
Mayen-Herrera, E. / Cortes, M. / Marx, S. E. / Sterz, R. | 2011
A571
ISPOR 3rd Latin America conference disclosure information for reserch presentations
| 2011
A573
ISPOR 3rd Latin America Conference Research Abstracts Author Index
| 2011
i
Table of Contents
| 2011
I
Instructions for Authors
| 2011
PCN2 A Retrospective Longitudinal Study of Treatment Patterns and Outcomes Among Patients with Unresectable Stage IIIc/IV Melanoma in Canada (Melody)
Osenenko, K. / Szabo, S. M. / Schultz, M. / Mihalcioiu, C. / Lane, S. / Levy, A. R. | 2011
PCN114 Cost Effectiveness of Adjuvant Cyclophosphamide in the Treatment of Breast Cancer in Spain
Walter, E. / Brennig, C. / Sch&#x00F6 / llbauer, V. | 2011
PCN143 Electronic Patient-Reported Outcome Monitoring in Testicular Cancer Patients
Giesinger, J. M. / Oberguggenberger, A. / Kemmler, G. / Gamper, E. / Steiner, H. / Sztankay, M. / Holzner, B. | 2011
PDB58 How Much Do Patients with Type 2 Diabetes Value Improvements in Dosing Convenience? Results from a Conjoint Study
Hauber, A. B. / Han, S. / Yang, J. C. / Gantz, I. / Tunceli, K. / Gonzalez, J. M. / Brodovicz, K. / Alexander, C. / Davies, M. / Lento, K. | 2011
PRS12 A Budget Impact Analysis to Estimate the Economic Impact Of Beclomethasone/Formoterol for the Treatment of Moderate to Severe Persistent Asthma in Six Spanish Regions
Darba, J. / Kaskens, L. | 2011
PDB11 Glycemic Outcomes Among Patients Receiving Exenatide BID or Liraglutide for Type 2 Diabetes in Clinical Practice: A Retrospective Analysis of the GE Centricity EMR Data
Best, J. H. / Wintle, M. / Saunders, W. B. / DeYoung, M. B. / Blickensderfer, A. / Maggs, D. | 2011
PHP9 Preditores Da quantidade De Medicamentos Tomados Em Pessoas Com DoenÇa Crónica
Pais-ribeiro, J. / Silva, I. / Meneses, R. / Pedro, L. / Cardoso, H. / Abreu, M. / Melo, V. / Martins, A. / Vilhena, E. / Mendon&#x00E7 et al. | 2011
PIH5 Replacing MMR By MMRV in Mexico: Assessement of Cost-Effectiveness Based on a Dynamic Transmission Model
Ouwens, M. / Macias, M. / Mascare&#x00F1 / as De Los Santos, A. H. / Gomez, J. A. / Sauboin, C. / Carre&#x00F1 / o Manjarrez, R. | 2011
PRS9 Budget Impact Analysis Of Immunotherapy in Patients with Grass Pollen Allergic Rhinitis
Westerhout, K. Y. / Verheggen, B. G. / Schreder, C. H. / Doering, C. / Augustin, M. | 2011
PCN134 Patient Preferences for Non-Small Cell Lung Cancer (NSCLC) Treatments
Bridges, J. F. / Mohamed, A. / Finnern, H. W. / Hauber, A. B. / Woehl, A. | 2011
PRS26 Direct Costs of Pneumonia in the United States: An Analysis of 2008 Medical Expenditure Panel Survey (MEPS) Data
Parkv, H. / Rascati, K. L. | 2011
PRS32 Cost-Effectiveness of Omalizumab in Severe Uncontrolled Allergic Asthma Using Rct and Real-World Evidence in the Dutch Setting
Stern, S. / van Nooten, F. / Groot, M. / Brown, R. | 2011
PRS43 Pharmacoeconomic Evaluation of Antibiotic Therapy of Community-Acquired Infections of the Lower Respiratory Tracts By the Use of Moxifloxacin Versus Clarithromycin in Ukraine
Mishchenko, O. / Iakovlieva, L. / Matyashova, N. | 2011
PSS2 Prevalence, Demographics and Treatment Characteristics of Visual Impairment Due to Diabetic Macular Edema in A Representative Canadian Cohort
Petrella, R. J. / Blouin, J. / Davies, B. / Barbeau, M. | 2011
PSS15 Burden of Chronic Tinnitus in Hungary
Kiss, Z. | 2011
PSS41 Impact on Quality of Patients With Active and Inactive Psoriasis in Spain
Dauden, E. / Herrera, E. / Puig, L. / S&#x00E1 / nchez-Carazo, J. L. / Toribio, J. / Caloto, M. T. / Nocea, G. | 2011
PCN6 Evaluacion Economica Del Dasatinib En El Tratamiento De La Leucemia Mieloide Cronica En Pacientes Resistentes Al Imatinib En Chile
Orozco, J. J. / Valencia, J. E. / Aiello, E. / Caputo, M. | 2011
PSS38 3-D Study - Description of the Care of the Dental Pain
Wierzba, C. / Auges, M. / Watt, M. / Taieb, C. | 2011
PCN126 Which Factors Can Affect Utilities?
Kang, E. / Lee, J. / Jeong, H. | 2011
PMD52 Workload in German Hospitals Caused by Routine Follow-up Services for Cardiac Implantable Electrical Devices (CIED)
Smala, A. / Vogtmann, T. | 2011
PND6 Outcomes of Antiepileptic Drugs Uses at Doses Above the Recommended Range Among Children with Structural-Metabolic Epilepsy in Malaysia
Salih, M. / Bahari, M. B. / Hassali, M. A. / Shafie, A. A. / Al-lela, O. Q. / Abd, A. Y. / Ganesan, V. | 2011
PND64 Cost-Minimization Analysis of IFNB-1B and Fingolimod among Multiple Sclerosis Patients in Germany
Pan, F. / Goh, J. / Wang, C. / Meinhardt, M. | 2011
PMS45 Cost-Utility and Budget Impact Analysis of Certolizumab Pegol Plus Methotrexate for the Treatment of Moderate-to-Severe Active Rheumatoid Arthritis in Greece
Maniadakis, N. / Boumpas, D. / Kourlaba, G. / Christou, P. / Anargiros, I. / Smets, E. / Purcaru, O. | 2011
PMS40 Economic Evaluation of Etanercept in Rheumatoid Arthritis from the Public Payer perspective in Brazil
Fernandes, R. A. / Takemoto, M. L. / Tolentino, A. C. / Takemoto, M. M. / Santos, P. M. / Mould, J. F. | 2011
PND21 Cost of Alzheimer'S Disease in Romania
Paveliu, M. S. / Tudose, C. / Tudose, F. | 2011
PMH69 Deprivation and Use of Atipycal Antipsychotics in Schizophrenia
Moisan, J. / Lauzier, S. / Vanasse, A. / Lesage, A. / Courteau, J. / Fleury, M. J. / Gregoire, J. P. | 2011
PMH42 Cost-Utility Analysis of Paliperidone Palmitate Long Acting Injection(PLAI) Versus Oral Atypical Antipsychotics in Non-Adherent Schizophrenia Patients
Kim, B. R. / Lee, T. J. / Woo, J. M. / Park, J. I. / Kwon, J. S. | 2011
PMH53 Follow-up of Health-Related Quality of Life in Young Heroin Users
Catal&#x00E0 / L. / Ferrer, M. / Sanchez-Niub&#x00F2 / A. / Brugal, M. T. / Domingo-Salvany, A. / Itinere, I. | 2011
PMH68 Differential Use of Extended and Instant Release Quetiapine: A Naturalistic Study of Finnish Inpatients with Schizophrenia Spectrum or Bipolar Disorders
Hallinen, T. / Soini, E. J. / Granstr&#x00F6 / m, O. / Ovaskainen, Y. / Leinonen, E. / Koponen, H. J. / H&#x00E4 / nninen, K. | 2011
PMS32 Economic Analysis of Etanercept in Rheumatoid Arthritis from a Public perspective in Venezuela
Fernandes, R. A. / Boada, V. / Mould, J. F. | 2011
PCV94 Dronedarone is Cost-Effective for the Prevention of Downstream Cardiovascular Morbidity and Mortality in Australian Patients with Atrial Fibrillation
Liew, D. / Lee, J. / Gonzalo, F. | 2011
PHP99 Reimbursing Telemonitoring in Europe: Are Payers Ready?
Flostrand, S. / Garde, E. / Toumi, M. | 2011
PGI30 Comparison of Health Related Quality of Life Between Hepatitis, Cirrhosis, Liver Transplantation and Hepatic Carcinoma: Results of the Come Study
Ciampichini, R. | 2011
PCV143 Implementation of Evidence-Based National Guidance on Venous Thrombo-Embolism Prophylaxis for Hospital Inpatients in England
Gericke, C. A. / Boiko, O. / Child, S. / Nokes, T. / Copplestone, A. / Sheaff, R. | 2011
PCN68 Cost-Effectiveness and Quality of Life Analysis of the Multicenter Itac02-01 Study: Prospective Randomized Comparison of Reduced Intensity Versus Non-Myeloablative Conditioning Regimen for Matched Related Allogeneic Stem Cell Transplantation
Le Corroller Soriano, A. G. / Siani, C. / Tabrizi, R. / Michallet, M. / Bay, J. O. / Fabre, R. / Boher, J. M. / Blaise, D. | 2011
PIH37 The Royal Road or the Middle Way? Public and Patient Preferences for Health Outcomes
Versteegh, M. / Brouwer, W. | 2011
PCV1 Costs, Length of Stay and ALL-Cause Mortality in Ruptured Versus Unruptured Cerebral Aneurysm Among Inpatients in the United States
Wallace, K. L. / Hashemi, L. / Minshall, M. E. | 2011
PHP11 The Use of Methylphenidate in A Group of Patients with Attention Deficit and Hyperactivity Disorder
Gomez-galicia, D. L. / Rodriguez-fragoso, L. / Lopez aymes, G. / S&#x00E1 / nchez-Alem&#x00E1 / n, M. / Reyes-esparza, J. A. | 2011
PHP46 PrÁctica Clínica Institucional En El Tratamiento De La Diabetes Mellitus Tipo 2 En MÉxico
Juarez-Garcia, A. / Vargas-Valencia, J. / Martinez-Rivera, G. / Sotelo-Guzm&#x00E1 / n, M. / Elias-L&#x00F3 / pez, J. I. / Zamora-Barron, M. / Rangel, S. | 2011
PCN5 Reduced Risk of Chemotherapy-Induced Nausea and Vomiting in Patients with Cancer Treated with Highly Emetogenic Chemotherapy and Antiemetic Prophylaxis With Palonosetron
Schwartzberg, L. / Jackson, J. / Jain, G. / Balu, S. | 2011
PIH7 The Efficiency of in Vitro Fertilization in Hungary 2000-2010
Gresz, M. / Varga, S. / Boncf&#x00F6 / ldi, K. / Sebesty&#x00E9 / n, A. / Kriszbacher, I. / Boncz, I. | 2011
PCN36 The Economic Impact of Treating Early Lung Cancer: A Systematic Review
Mahar, A. L. / Fong, R. / Johnson, A. | 2011
PCN99 Cost-Effectiveness of Dasatinib versus High-Dose Imatinib and Nilotinib in Patients with Chronic Myeloid Leukaemia Resistant to Standard-Dose Imatinib in Portugal
Darba, J. / Kaskens, L. / Abecasis, M. / Vitorino, R. / Carrasco, J. | 2011
PCV108 Deriving Utility Values from the General Population for Dronedarone in the Treatment of Atrial Fibrillation
Adams, J. / Lee, J. / Gonzalo, F. | 2011
PMD56 A Systematic Literature review on the Clinical and Economic outcomes attributable to the Use of Hemostatic Matrix during Tonsillectomy and Adenoidectomy
Williams, E. N. / Kreuwel, H. / Krishnan, S. | 2011
PSU12 Estimating Cost and Resource Use for Whole Brain Radiation Versus Stereotactic Radiosurgery Treatments Among Brain Metastasis Patients
Ganguli, A. / Dacosta Byfield, S. / Teitelbaum, A. / Ray, S. | 2011
HG1 Applying Frailty Model in Longitudinal Survivals of Chronic Diseases
Li, Y. / Holtzer-Goor, K. / Uyl-de Groot, C. / Al, M. | 2011
PIN44 Cost-Effectiveness of Quadrivalent HPV Vaccination in Germany Using A Dynamic Transmission Model
Schobert, D. / Remy, V. / Sch&#x00F6 / ffski, O. | 2011
PMD22 Economic Evaluation of Amino-Terminal pro-Brain Natriuretic Peptide (NT-proBNP) Test in Patients with Dyspnea attending to Emergency Department (ED) in Spain
Llorens, P. / Moreu, J. / Rodr&#x00ED / guez, J. / P&#x00E9 / rez Alc&#x00E1 / ntara, F. | 2011
PIN106 HIV Screening Programme in Community Pharmacies of the Basque Country
Gorostiza, I. / Elizondo, I. / Braceras, L. | 2011
PMD68 Purchasing and Adopting Cardiovascular Devices: A Global Survey
Menzin, J. / Neumann, P. / Duczakowski, C. / Woodward, R. M. / Friedman, M. / Outlaw, J. J. / Durtschi, A. | 2011
PND4 A Meta-analysis of the Duration of Clinical Effect of onabotulinumtoxina in Cervical Dystonia
Marsh, W. / Monroe, D. / Gallagher, C. | 2011
PHP52 Inequalities in the Utilization of Home Hospice Services in Hungary
Turcsanyi, K. / Domj&#x00E1 / n, P. / Pakai, A. / Gombos, G. / goston, I. / Vas, G. / Molics, B. / li&#x00E1 / s, Z. et al. | 2011
PHP71 Effect of SIADH on Patient outcomes and Health Care Resource Utilization in Hospitalized Patients
Amin, A. / Deitelzweig, S. / Lin, J. / Christian, R. / Baumer, D. / Lowe, T. | 2011
PIH25 Cost-Effectiveness of Interventions Against Childhood Obesity
Ramos-Go&#x00F1 / i, J. M. / Valc&#x00E1 / rcel-Nazco, C. / Castilla-Rodr&#x00ED / guez, I. | 2011
PIH10 Examination of Female Balance Maintenance Ability in Major Life Stages
Hock, M. / Dakos, Z. / D&#x00E1 / lnoki, x. / Hajnal, B. / Kr&#x00E1 / nicz, J. / Kriszbacher, I. / Boncz, I. / B&#x00F3 et al. | 2011
PSY19 Economic Costs of Chemotherapy-Induced Febrile Neutropenia Among Patients with Non-Hodgkin'S Lymphoma in European Clinical Practice
Weycker, D. / Danel, A. / Marciniak, A. / Bendall, K. / Lipsitz, M. / Pettengell, R. | 2011
PSY24 Pregabalin is Cost-Saving in Comparison with Gabapentin Treated Patients when Added to Existing Therapy in the Management of Painful Radiculopathies
Sicras-Mainar, A. / Navarro-Artieda, R. / Planas, A. / Ruiz, L. / Rejas, J. | 2011
PSY29 Economic Evaluation of Capsaicin Patch 8% in the Treatment of Neuropathic Pain in Austria
Brennig, C. / Walter, E. / Sch&#x00F6 / llbauer, V. | 2011
PSY54 A Cost Estimation of the New Guideline to Treat Bleeding Episodes in Patients with Haemophilia and Inhibitors in Iran
Jaberidoost, M. / Abdollahiasl, A. / Nikfar, S. / Khatibi, M. | 2011
PIH16 analyzing the Adverse Drug reactions of Geriatric Population at A regional Academic Hospital of southern Taiwan
Lin, P. T. / Cheng, Y. D. | 2011
PIH40 Designing a Disease-Specific Patient Reported Outcome (PRO) for a Rare Disease: Assessing the Reliability, Validity, and Responsiveness of the Hunter Syndrome - Functional Outcomes for Clinical Understanding Scale (HS-Focus)
Wiklund, I. / Raluy, M. / Jangelind, Y. / Whiteman, D. A. / Conway, A. M. / Pang, F. / Stull, D. E. / Chen, W. H. | 2011
PSY14 Differences in Outpatient Care Among Fibromyalgia Patients on Duloxetine Versus Pregabalin
Zhao, Y. / Sun, P. / Sun, S. | 2011
PHP91 Patient Safety Activities Associated with Hospital Pharmacy in A Nationwide Survey on Management System for Patient Safety
Hirose, M. / Imanaka, Y. | 2011
PHP102 Biosimilars: Pricing & Reimbursement in Germany: Key Insights From Sickness Funds
Chaudhari, S. D. / Bache, B. | 2011
PHP106 when is Lower Level Evidence of Effectiveness Acceptable in Reimbursement Decisions?: A Decision Algorithm to Guide Policy Makers
de Groot, S. / Rijnsburger, A. / Heymans, J. / Redekop, W. | 2011
PHP121 The Role of Molecular Tests in Shaping Comparative Effectiveness Review (CER)
Hughes, K. E. / Williams, R. | 2011
PCV34 Improving Global Vascular Risk Management (GVRM) Using the COSEHC Cardiovascular Risk Assessment Tool
Ferrario, C. / Moore, M. / Simmons, D. / Colby, C. / Exuzides, A. / Panjabi, S. | 2011
PHP22 Use of Decision Modeling to Estimate the Negative Impact of Tobacco Use on Health Care Costs and Health Disparities in People Living with HIV
Burbano-Levy, X. / Miguez, M. J. / Thompson, M. / Medina, A. / Quiros, C. / Malow, R. | 2011
PRM4 A MIXED-Effects Piecewise Linear Model Of The Rate Of Lung Function Decline Before And After Inhaled Corticosteroids In An Observational Study Of Children With Cystic FIBROSIS
Pasta, D. J. / Rasouliyan, L. | 2011
PCN93 Cost-Effectiveness of Treatment with New Agents in Advanced Non-Small-Cell Lung Cancer: A Systematic Review
Bongers, M. L. / Coupe, V. M. / Jansma, E. P. / Smit, E. F. / Uyl-de Groot, C. | 2011
PSS31 Association Between Eq-5D and Dermatology Life Quality Index (Dlqi) in Patients With Chronic Hand Eczema
Cortesi, P. A. / Scalone, L. / De Pit&#x00E0 / O. / Angelini, G. / Cristaudo, A. / Girolomoni, G. / Gola, M. / Ayala, F. / Cannav&#x00F2 et al. | 2011
PCN190 Use of Surrogate Measures of Survival in Economic Evaluations of Metastatic Breast Cancer Treatments
Beauchemin, C. / Cooper, D. / Lachaine, J. | 2011
PRS8 Cost-Effectiveness of an Ambulatory program of Pulmonary rehabilitation following Acute Exacerbations of Copd in Colombia
Giraldo, L. F. / Brito, K. P. / Rodriguez, P. | 2011
AD3 Assessing The Compliance And Persistence of Allergen Immunotherapy In Allergic Rhinitis Using A Retrospective Pharmacy Database From The Netherlands
Kiel, M. A. / Gerth van Wijk, R. / R&#x00F6 / der, E. / Al, M. J. / Hop, W. C. / Rutten-van M&#x00F6 / lken, M. P. | 2011
PMD3 Biochemical Markers for the Identification of Intracranial Injury Following Minor Head injury: A Systematic Review and Meta-Analysis
Pickering, A. / Fitzgerald, P. / Harnan, S. E. / Pandor, A. / Goodacre, S. W. | 2011
PUK7 3 Years Follow Up of the Pharmacotherapy Cost of Patients with Kidney Transplantation in Bulgaria
Georgieva, S. S. / Stoimenova, A. / Petrova, G. | 2011
CN3 Validation Study Of The Baseline Quality Of Life As A Prognostic Indicator Of SURVIVAL: A Pooled Analysis Of Individual Patient Data From NCIC Clinical Trials
Ediebah, D. E. / Quinten, C. / Coens, C. / Zikos, E. / Ringash, J. / Gotay, C. / Flechtner, H. H. / Osoba, D. / King, M. / Cleeland, C. | 2011
PMD81 Decision Analytic Models Used in Estimating the Cost-Effectiveness of Drug-Eluting Stents versus Bare-Metal Stents
Burgers, L. T. / Redekop, W. / Severens, J. L. | 2011
PMD84 Assessing Cost Effectiveness and Value of Further Research When Data are Sparse: Negative Pressure Wound Therapy for Severe Pressure Ulcers
Soares, M. O. | 2011
PMD83 Using Five Existing Models to Comprehensively Model the Cost-Effectiveness of A High Definition CT Scanner in A Coronary Artery Disease Population: A Nice Diagnostic Guidance Project
Burgers, L. T. / Redekop, W. / Westwood, M. / Lhachimi, S. / Severens, J. L. / Armstrong, N. / Sculpher, M. J. / Walker, S. / Mckenna, C. / Al, M. J. | 2011
PSU3 Prevalence Rates of Surgical Complications Among Tuberous Sclerosis Complex Patients with Surgical Removal of Subependymal Giant Cell Astrocytoma: A Real-World National Retrospective Cohort Study
Sun, P. / Liu, Z. / Rogerio, J. / Guo, A. / Garay, C. / Kohrman, M. | 2011
PSU19 the Doors-Study of On-Pump Versus Off-Pump Coronary Artery bypass Grafting: A Post Hoc Analysis of Methods for Multiple Imputation of Missing Data in Economic Evaluation
Ehlers, L. / Fenger-gr&#x00F8 / n, M. / Beck, S. S. / Houlind, K. / Lauridsen, J. | 2011
PIN26 Economic and Health Related Quality of Life (HRQL) Comparison of Lopinavir/Ritonavir (LPV/R) and Atazanavir Plus Ritonavir (ATV+RTV)-Based Regimens for Antiretroviral (ARV) Experienced Brazilian Patients in 2011
Simpson, K. / Baran, R. / Dietz, B. | 2011
HT2 Value Based Pricing: One Threshold too Far for the United Kingdom
Roberts, G. | 2011
PCV89 Cost-Effectiveness Analysis of Rosuvastatin Versus Generic Atorvastatin in Patients at High Cardiovascular Risk in Spain
Brosa, M. / Barrios, V. / Lobos, J. M. / Serrano, A. / Capel, M. / Alvarez, C. | 2011
PCV96 Cost-Utility Analysis of the Long-Term Cardiovascular Prevention Program in Russian Federation as an Argument for the Widespread Introduction of Preventive Technologies Into Clinical Practice
Kontsevaya, A. / Kalinina, A. / Deev, A. | 2011
PCV119 Relationship Between Quality of Life and Level of Cardiovascular Risk and Comorbidities in Spanish Hipertensive Patients-Alhambra Study
Font, B. / Lahoz, R. / Salazar, J. / Roca-cusachs, A. / Abell&#x00E1 / n, A. | 2011
PSY7 Budget Impact Analysis of Bendamustine in the Treatment of Multiple Myeloma in Spain
Mateos, M. V. / Collar, J. M. | 2011
PIN81 Cost-Effectiveness Analysis of Peg-Interferon Alpha-2A Plus Ribavirin Versus Conventional Interferon Alpha-2A Plus Ribavirin for the Treatment of Chronic Hepatitis C in China
Chen, W. / Wei, L. | 2011
PMD8 Systematic Review of the Impact Different Metal Femoral Stems (MFSS) Have on Patient outcomes in total Hip replacement (THR) Due to Osteoarthritis (OA)
Edwards, S. J. / Hamilton, V. / Nherera, L. / Arber, M. | 2011
PIN89 Do Patients and Physicians Have Similar Preferences Chronic Hepatitis B Treatment Outcomes in Turkey?
Mohamed, A. / Johnson, F. R. / Hauber, A. B. / Lescrauwaet, B. / Saylan, M. | 2011
PIN91 Sensitivity of Pro's in Evaluating Adverse Events in People Receiving Influenza Vaccination
Wade, A. / Crawford, G. / Pumford, N. / Mcconnachie, A. | 2011
PIN102 National Cost Savings from the Brazilian HIV/AIDS Antiretroviral Universal Access Program: Analysis Versus Canada and Australia
Becker, R. V. / Teich, V. / Pepe, C. | 2011
PMH70 Economic Impact of Focal Epilepsy in Spain: Results of the Espera Study
Villanueva, V. / Brosa, M. / Doz, M. / Aguade, A. S. / Levy-bachelot, L. / Lahuerta, J. / Hern&#x00E1 / ndez-Pastor, L. J. | 2011
PMS75 Explanatory Factors for the Rheumatoid Arthritis Patients' Access to Biological Agents in 15 European Countries
Laires, P. A. / Exposto, F. / Barosa, P. / Hormigos, B. / Martins, A. P. | 2011
PCV18 Relative Efficacy of Bivalirudin vs. Heparin Alone in STEMI Patients Treated with Primary PCI – an Indirect Treatment Comparison
Medic, G. / Schwenkglenks, M. / Eijgelshoven, I. / Smith, A. / Day, J. / Plent, S. / Bergman, G. / Toward, T. | 2011
PCV39 Heparin-Induced Thrombocytopenia Type II in Times of Demographic Changes – Epidemiological and Economic Aspects in Germany
Schopohl, D. / Berger, K. / Schramm, W. | 2011
PCV68 Pharmacogenomic Testing for Warfarin Use in Typical outpatient Settings Lowers Health Care Costs: The Medco-Mayo Warfarin Effectiveness Study
Aubert, R. E. / Epstein, R. S. / Yao, J. / O'Kane, D. J. / Tinnirello, J. / Teagarden, J. R. / Moyer, T. P. | 2011
PCV58 the Impact of Comorbid Mental Illness on Costs of Health Care for Inpatients with Heart Failure
Shimizu, S. / Ishikawa, K. B. / Ito, H. / Fushimi, K. | 2011
PCV82 Simulation of Long-Term Clinical Benefits and Costs of Add-On Therapy with Aliskiren in Hypertensive Patients with Diabetic Nephropathy: A German Statutory Health Insurance Perspective
Graf von der Schulenburg, J. M. / Weycker, D. / Kaiser, E. / Neidhardt, K. / Brede, Y. | 2011
PCV93 the Polypill in the Primary Prevention of Cardiovascular Disease: Cost-Effectiveness in the Dutch Population
Van Gils, P. F. / Hamberg-van Reenen, H. H. / Over, E. / de Wit, G. A. / van den Berg, M. / Schuit, A. J. / Engelfriet, P. M. | 2011
PCN44 Cost-of-Illness Study of Human Papillomavirus Cancers in England
Tempest, M. J. / Thurston, S. / Carroll, S. / Charman, F. / Rajoriya, F. | 2011
PSY10 Budget Impact Analysis of Somatuline Autogel in the Management of Acromegaly in Spain
Brosa, M. / Betoret, I. / Tapias, G. | 2011
PSY18 Resource Consumption Evaluation for Ketoprophene, Ketorolac, Parecoxib and Tenoxicam at Orthopedic Surgery Post-Operation in Brazilian Patients from Private Payers Perspective
Fujii, R. K. / Mould, J. F. / Lanzara, G. | 2011
PCN157 The Impact of a Patient Support Program on Access to Oral Oncology Therapy in the United States
Pashos, C. L. / Cragin, L. S. / Khan, Z. M. | 2011
PCN185 A Multi-Country Retrospective Study of Patient Characteristics and Treatment Patterns in Chronic Myeloid Leukemia
Mitra, D. / Trask, P. C. / Iyer, S. / Candrilli, S. D. / Kaye, J. A. | 2011
PDB63 Anti-Diabetic Therapeutic Strategies for Type 2 Diabetes Patients with Chronic Kidney Disease in France
Amalric, F. / Attali, C. / Joly, D. / Simon, D. / Verges, B. / Grandfils, N. / Briand, Y. | 2011
PCN9 Adverse Events Among Patients with Metastatic Colorectal Cancer Treated with Monoclonal antibodies in Clinical Practice
Emons, M. F. / Dean, B. / Yu, H. T. / Barber, B. / Malin, J. / Zhao, Z. | 2011
PCN11 Bevacizumab in Combination with Chemotherapy for the First-Line Treatment of Metastatic Colorectal Cancer
Ubago, R. / Castillo, M. A. / Flores, S. / Beltr&#x00E1 / n, C. | 2011
PCN13 Treatment of Patients with Multiple Myeloma (TLN-Registry): A “Real Life” Overview of Treatment by Office-Based Oncologists in Germany
Hartmann, H. / Knauf, W. / Abenhardt, W. / Aldaoud, A. / Lerchenm&#x00FC / ller, C. / Koska, M. | 2011
PCV2 Evaluation of the prophylaxis Patterns and 90 Day outcome Events in Hospitalized Medically Ill Patients
Baser, O. / Wang, L. | 2011
PSS30 Assessment of Utility Loss From Diabetic Macular Edema Based on Restore Trial
Knudsen, M. S. / Thomas, S. / Gallagher, M. / Mitchell, P. | 2011
PHP23 La Aceptacion De Las Vacunas En Los programas Nacionales De inmunizacion En Latina America: Un Estudio Comparativo
Jones, K. | 2011
PHP42 Calidad De Vida Relacionada Con La Salud Y Apoyo Social En Estudiantes De Farmacia En Venezuela
Parra, G. / Bastardo, Y. | 2011
PMS5 analisis De Costo-Efectividad De Agentes Biologicos En El Tratamiento De Pacientes Con Artritis reumatoide Activa Y respuesta insuficiente A Farme Tradicionales Desde La perspectiva Del Sistema Publico De Salud En México
Carlos, F. / Aguirre, A. / Pel&#x00E1 / ez-Ballestas, I. / Ramos, E. | 2011
PRM5 Incorporating Equity Into Developing and Implementing Evidence-Based Clinical Practice Guidelines
Eslava-Schmalbach, J. H. / Sandoval Vargas, G. / Mosquera, P. A. | 2011
PSY3 Use Of A Discrete Event Simulation Model To Estimate Long Term Economic Outcomes Of Bariatric Surgery In Morbidly-Obese, Type-2 Diabetic Patients In Mexico
Zanela, O. O. / Cabra, H. A. / Anaya, P. / Rodriguez, S. / Melendez, G. / Rupprecht, F. | 2011
PMH11 Psychotropic-Related Hip Fractures Around the World: A Meta-Analysis
Young, J. / Pepper, G. A. / Oderda, L. / Asche, C. V. | 2011
PRS44 Cost Utility Analysis of Omalizumab Therapy for Severe Asthma Patients in Thailand
Sakul-isariyaporn, C. / Lertiendumrong, J. / Vasavid, C. / Pachanee, K. | 2011
PRM12 An Application of a Proposed Framework for Formulary Listing in Low-income Countries: Case of Côte d'Ivoire
Diaby, V. / Lachaine, J. | 2011
PRM31 Data Pooling of Patient-Reported Outcomes in Clinical Trials: Evaluation of Structual Equation Modelling for Assessing Equivalence
Nixon, M. / Burgess, A. J. | 2011
PRM23 General Methodological Issues in Cost-Effectiveness Analysis Inspired by the Assessment of Dasatinib, Nilotinib and Imatinib for Chronic Myeloid Leukaemia
Hoyle, M. W. | 2011
PSS14 Burden of Disease in Patients With Severe Chronic Hand Eczema in Germany
Diepgen, T. L. / Purwins, S. / Posthumus, J. / Kuessner, D. / Augustin, M. | 2011
PRM57 Revisiting HPV Vaccination: Why Existing CEAs Underestimate the Vaccine'S Cost-Effectiveness and Incorrectly Estimate Its Threshold Price
O'Mahony, J. | 2011
HS4 Impacto Economico En La Atencion Medica De Enfermedades Asociadas Al Tabaquismo En Una Poblacion Mexicana
P&#x00E9 / rez Zincer, F. / Quintana Carrillo, R. / Barrios Nanni, R. / Chagoya Bello, J. / Ramos Reyna, E. / Reynales Shigematsu, L. | 2011
PMS2 Osteoporosis Medication Might Help reduce the incidence of Second Hip Fractures?
Sebesty&#x00E9 / n, A. / S&#x00E1 / ndor, J. / Betlehem, J. / Boncz, I. | 2011
PCN187 Treatment Patterns in Patients with Metastatic Melanoma
Zhao, Z. / Wang, S. / Barber, B. / Gao, S. K. / Wagner, V. | 2011
PCN63 Cost-Effectiveness of Sunitinib in Patients with Advanced or Metastatic Pancreatic Neuroendocrine Tumors in Portugal
Soares, M. / In&#x00EA / s, M. / Contente, M. | 2011
PCN95 The Cost-Effectiveness of Aprepitant for the Prevention of Nausea and Vomiting Induced by Moderately Emetogenic Chemotherapy in Breast Cancer Patients Compared to Current Clinical Practice in Scotland
Nikoglou, E. / Humphreys, S. / Pellissier, J. / O' Regan, C. | 2011
PCN115 Cost of Skeletal-Related Events (SREs) in Patients with Bone Metastases to solid Tumours Based on the Health Resource Utilisation (HRU) Collected in a Prospective European Multinational Observational Study
Hechmati, G. / Cure, S. / Gou&#x00E9 / po, A. / Hoefeler, H. / Lorusso, V. / L&#x00FC / ftner, D. / Dur&#x00E1 / n, I. et al. | 2011
PDB57 Polish Health Care System for Diabetic Patients: The Analysis of Current Health Care System and the Need of Community Pharmacy Implementation
Rzeszotarska, O. / Hermanowski, T. R. / Rdzanek, M. | 2011
PCN198 Review of Economic Assessments of Emerging Genomic Technologies in Oncology
Quecedo, L. / Del Llano, J. | 2011
PRS37 The Impact of Regional Data on Cost-Effectiveness Results of Salmeterol/Fluticasone Propionate (SAL/FP) + Fenoterol/Ipratropium Bromide (Fen/IB) Versus Fen/IB Only in COPD Treatment
Yagudina, R. / Kulikov, A. / Chuchalin, A. G. / Belevsky, A. / Demko, I. V. / Lomakin, A. / Shchurov, D. | 2011
PRS53 Further Developments of the Asthma Life Impact Scale (ALIS)
Crawford, S. R. / McKenna, S. / Twiss, J. / Tammaru, M. / Oprandi, N. C. | 2011
IN1 Evaluacion De COSTO-Efectividad Con El Uso De Linezolid Para El Tratamiento De Infecciones Complicadas De Piel Y Tejidos Blandos
Vargas-Valencia, J. J. / Sotelo-Guzm&#x00E1 / n, M. / D&#x00ED / az-Ponce, H. / Galindo-Su&#x00E1 / rez, R. M. / Muci&#x00F1 / o-Ortega, E. / Mould-Quevedo, J. | 2011
PIH2 Addressing Childhood Obesity In Mexico: Savings On Health Care Expenditures From Regulating Food And Beverage Sales In Basic Education Schools
Guajardo-Barron, V. J. / Gutierrez-Delgado, M. C. / Rivera-Pe&#x00F1 / a, G. | 2011
PMS1 Meta-analisis De La Efectividad Y Seguridad Del Uso De Celecoxib En El Manejo Del Dolor Cronico vs Otros Cox-2 En Pacientes Con Osteartritis O Artritis reumatoide
Vargas-Valencia, J. J. / Granados-Soto, V. / Galindo-Su&#x00E1 / rez, R. M. / Mould-Quevedo, J. | 2011
PIN20 Clinical and Economical Impact of Pneumococcal Vaccination in Spanish Adult Population Measured by a Dynamic Model
Pradas, R. / Gil de Miguel, A. / Alvaro, A. / Gil-Prieto, R. / Guijarro, P. / Lorente, R. / Anto&#x00F1 / anzas, F. | 2011
PIN71 Pharmacoeconomic Analysis of Treatment of Community-Acquired Pneumonia (CAP)
Zaitsev, A. / Synopalnikov, A. / Tyrsin, O. | 2011
PIN76 Cost Effectiveness analysis of Vaccination with 13-Valent (PCV13) and 23-Valent (PPV23) Pneumococcal Vaccines for Senior Adults in Brazil
Fujii, R. K. / Mould, J. F. / Presa, J. / Jardim, E. / Sato, R. / Strutton, D. R. | 2011
PHP5 Analysis of Linked Medical Claims Data for Preinvestigation in Modeling Studies
Einzinger, P. / Zauner, G. / Popper, N. / Endel, G. / Breitenecker, F. | 2011
PHP29 Impact of Different Pharmaceutical Distribution Systems on the Access to Pharmaceutical Products in Six European Countries
Walter, E. / Dragosits, A. / Said, M. | 2011
PIN107 Tobramycin Inhaled Solution Utilization by Cystic Fibrosis Patients: An Analysis with the RAMQ Database
Lachaine, J. / Beauchemin, C. / Barbeau, M. | 2011
PIN112 Use of Dynamic Models to Measure Health Outcomes of Pneumococcal Vaccination in Spanish Adult Population
Pradas, R. / Guijarro, P. / de Salas-Cansado, M. / Lorente, R. / Anto&#x00F1 / anzas, F. | 2011
PHP109 Tendering of Biosimilars in the UK – Does Launch Price Actually Matter?
Viejo Viejo, I. | 2011
PIN85 Costs of Influenza and Influenza Like Illness from the Employer's Perspective in Poland
Kawecka, K. / Wrona, W. / Hermanowski, T. | 2011
PSY52 Impact of Two Different Treatment Approaches on Epidemiology of inhibitor Hemophilia in Russia
Vorobyev, P. A. / Borisenko, O. / Krasnova, L. / Zhulyov, Y. / Bezmelnitsyna, L. | 2011
PMS12 A Budget Impact Model for the Use of Abatacept as a First Biologic Treatment for Rheumatoid Arthritis in Italy
Iannazzo, S. / Didoni, G. / Crocchiolo, D. | 2011
PND23 Cost of the Informal Care of Multiple Sclerosis in Spain
Gubieras, L. / Casado, V. / Romero-Pinel, L. / Matas, E. / Bau, L. / Mart&#x00ED / nez-Y&#x00E9 / lamos, S. / Arbizu, T. | 2011
PUK1 Belatacept Versus Tacrolimus: Results of an Indirect Analysis from a Systematic Review of Immunosuppressive Therapies for Kidney Transplant Recipients
Sidhu, M. / Odeyemi, A. O. / Hart, W. M. / Dada, B. R. | 2011
PIN60 Cost-Effectiveness of Telbivudine in First Line Treatment of Hbeag-Positive Patients with Chronic Hepatitis B (CHB) in the Turkish Health Care Setting
Pala, M. / Sahin, U. | 2011
PHP19 Does Pharmaceutical Price Regulation Affect the Adoption of Generic Competition in the OECD?
Varol, N. / Costa-i-Font, J. / McGuire, A. J. | 2011
PMH9 Prescribing Patterns and Cost of Drugs for Alzheimer's Disease
Truter, I. | 2011
PMS1 Tumor Necrosis Factor Alpha Inhibitors for the Treatment of Active Ankylosing Spondylitis
Ubago, R. / Castillo, M. A. / Mar&#x00ED / n, R. / Flores, S. / Rodr&#x00ED / guez, R. | 2011
PCV131 Cardiovascular Drug Utilization in Relation to Age in Nis Region
Kodela, B. / Aleksi&#x0107 / G. / Mili&#x0107 / evi&#x0107 / Veli&#x010D / kovi&#x0107 / R. | 2011
PCN201 Cost-Effectiveness Literature on Cancer Therapies, Trends and the Influence of Industry Involvement on Outcomes
Al-Badriyeh, D. / Al-Okka, R. / Al-Ameri, M. | 2011
PDB16 First Results of the Post-Marketing Survey of Vildagliptin in France
Attali, C. / Bringer, J. / Simon, D. / Eschw&#x00E8 / ge, E. / Deschaseaux, C. / Dejager, S. / Quere, S. / Bouee, S. / Detournay, B. | 2011
PIH43 Changes in Health-Related Behaviours and their Impact on Academic Achievement and Health-Related Quality of Life (HRQOL) Among Spanish Adolescents
Rajmil, L. / L&#x00F3 / pez-Aguil&#x00E0 / S. / Palacio-Vieira, J. A. / Alonso, J. | 2011
PRM26 A Literature Review of Methods Used to Estimate Mean Preference-Based Utilities for Comorbidities Using Published Summary Statistics
Ara, R. / Wailoo, A. J. | 2011
PRM35 Agreement Between Patients' Self-Report and Physicians' Prescriptions on Drugs and Vaccine Exposure: The International PGRX Database Experience
Grimaldi-Bensouda, L. / Rossignol, M. / Aubrun, E. / Benichou, J. / Abenhaim, L. | 2011
PCN1 Selecting a Mix of Prevention Strategies Against Cervical Cancer for Maximum Efficiency with an Optimisation Program
Demarteau, N. / Gomez, J. A. / Lorenzato, F. / Standaert, B. | 2011
PCV31 Cerebral Hemorrhage and Transient Ischemic Attack Affected by Meteorological Factors
Kriszbacher, I. / Boncz, I. / Szalai, M. / Sebesty&#x00E9 / n, A. / Szili, R. / Kornya, L. / Radnai, Z. / Csoboth, I. | 2011
PCV36 High Dose and Long-Term Safety of Systemic Corticosteroids in the Treatment of Polymylagia Rheumatica and Vasculitis: A Systematic Review
Nyssen, O. P. / Gauthier, A. / Schmitt, C. / Levy, V. / Cognet, M. / Aguiar-ibanez, R. | 2011
PCV40 Budget Impact Model After the Introduction of Vernakalant in Spain
Nocea Pulfer, G. / Caloto Gonzalez, M. T. / Mart&#x00ED / n Martinez, A. | 2011
PCN144 Health-Related Quality of Life in Prostate Cancer – One Year Follow-up and Comparison with General Population Norms
Roine, R. / Bergius, S. / F&#x00E4 / rkkil&#x00E4 / N. / Muhonen, T. / R&#x00E4 / s&#x00E4 / nen, P. / Sintonen, H. et al. | 2011
PUK5 ANÁlisis Comparativo De Costos Del Tratamiento Para La Anemia Renal Con Metoxi POLIETILENGLICOL-Eritropoyetina Beta (MIRCERA®) VS. Eritropoyetina ALFA
Medina G&#x00F3 / mez, J. L. | 2011
HG4 The Value of Heterogeneity for Cost-Effectiveness Subgroup Analysis: Theoretical Framework and Application
Espinoza, M. / Manca, A. / Claxton, K. / Sculpher, M. J. | 2011
PMS55 Persistence to Osteoporosis Treatment and its association to the Risk of Fracture Among Women in Taiwan
Ling, Y. L. / Tang, C. H. / Huang, K. C. / Chang, W. L. | 2011
PND27 Economic Analysis of Cost Per Episode of Care for Arm Spasticity and Cervical Dystonia: Comparison of Two Botulinum Toxin A Preparations in 20 Countries
Roze, S. / Marty, R. / Kurth, H. / Godard, A. | 2011
PMS8 Prevalence of Clinical Risk Factors for Fractures in the Canadian Multicentre Osteoporosis Study
Burge, R. / Ionnadis, G. / Adachi, J. / Papadimitropoulos, M. | 2011
PUK4 Comparing Projected Outcomes of Renal Transplant Recipients Based on Trial Endpoint of Renal Function and Receiving Different Immunosuppressive Regimens in the United States
Levy, A. / Briggs, A. / Johnston, K. / Schnitzler, M. / Litalien, G. J. / Yuan, Y. / Kasiske, B. | 2011
PHP69 Can We Increase Hospital Revenue with Different Neuromuscular Blockers? An Analysis of Saving Cost for Hospital Budget with Time Saving Effect of Different Neuromuscular Blockers in Short Operations
Kockaya, G. / Daylan Kockaya, P. / Wertheimer, A. / Ozbagr&#x00FD / ac&#x00FD / k, O. / Oba, S. | 2011
PHP72 Evidence-Based Priority Setting for the National Health Development Plan of Thailand
Patcharanarumol, W. / Bundhamcharoen, K. / Poungkantha, W. / Prakongsai, P. / Tangcharoensathien, V. | 2011
PMS64 Sensitivity of Pro'S to Detect Changes in Quality of Life in Patients Treated with a Biologic Agent
Pumford, N. / Wade, A. / Crawford, G. / Mcconnachie, A. | 2011
PND32 Cost-Utility Analysis of Ropinirole in Parkinson'S Disease (PD) Treatment
Zerda, I. / Drozdz, A. / Brzyski, D. / Pochopien, M. / Gwiosda, B. / Lisiecka, B. / Barlog, D. / Glogowski, C. / Dziurda, D. / Rys, P. | 2011
PIN57 Cost-Effectiveness of the New Guidelines for the Prevention of Mother to Child Transmission of HIV in Uganda
Kuznik, A. / Lamorde, M. / Semeere, A. / Castelnuovo, B. / Hermans, S. / Auerbach, B. / Ssewankambo, F. / Ssennono, M. / Sempa, J. / Mpanga Sebuyira, L. | 2011
PUK10 Cost-Effectiveness Analysis of Solifenacin Versus Oxybutynin Immediate-Release in the Treatment of Patients with Overactive Bladder in the United Kingdom
Hart, W. M. / Munro, V. / Retsa, P. | 2011
PHP10 Two Phases Study on the Perspective of Health Care Professionals on Current Mechanisms for Authorizing the Prescription of Specifically Controlled Medicines in Spain
Orozco, D. / Basora Gallisa, J. / Garcia, L. / Paz, S. / Lizan, L. | 2011
PHP36 Perceptions of Policy Makers and Science Advice Body Staff on Science Advice in Health in Europe
Conde Espejo, P. / Palma Ruiz, M. / Sarria-Santamera, A. / Segovia, C. | 2011
PCV32 Population Attributable Risk (PAR) of Macrovascular Events Associated with HbA1C, Blood Pressure or Weight in Patients with Type 2 Diabetes Mellitus: Evidence from a Dutch Cohort
Heintjes, E. / Penning-van Beest, F. J. / Parasuraman, S. V. / Grandy, S. / Pollack, M. / Herings, R. M. | 2011
PGI12 Gastroesophageal Reflux Disease Patients Who Switched from a Branded Proton Pump Inhibitor to a Generic One and Vice Versa: A Cost Comparison
Xie, L. / Baser, E. / Wang, L. / Baser, O. | 2011
PDB69 Prescription Pattern Study of Type 2 Diabetes Mellitus in Iran
Soleymani, F. / Farshchi, A. / Haerizadeh, M. | 2011
PDB32 Cost of Diabetes and its Complications in Poland: Preliminary Results
Lesniowska, J. / Skrzekowska-Baran, I. | 2011
PDB39 Cost-Effectiveness of Saxagliptin Compared to Sitagliptin for the Treatment of Patients with Type 2 Diabetes Mellitus (T2DM)
Hutchings, A. / Tolley, K. / Achana, F. / Brereton, N. J. / Lebmeier, M. / Mesa, O. A. | 2011
PCN16 Disease Burden and Treatment outcomes in Second-Line Therapy of Patients with Estrogen-Receptor Positive (ER+) Advanced Breast Cancer: A Review of the Literature
Boswell, K. A. / Wang, X. / Shah, M. V. / Aapro, M. S. | 2011
PDB56 Development of a New Measure for Assessing Health Related Quality of Life (HRQOL) in Patients with Primary Hyperparathyroidism (PHPQoL)
Farrerons, J. / Mu&#x00F1 / oz, M. / Puig, M. / Villabona, C. / Webb, S. / Badia, X. | 2011
PCN6 Impact of 5-HT3 Receptor Antagonist Selection Within Triple Antiemetic Regimens on the Risk of Uncontrolled Chemotherapy-Induced Nausea in Patients with Cancer Treated with Highly Emetogenic Chemotherapy
Schwartzberg, L. / Jackson, J. / Jain, G. / Balu, S. | 2011
PCN32 Cost Savings With Bevacizumab Compared to Sunitinib in the Treatment of MRCC
Benkovic, V. / Jelec, D. / Antolic, S. / Stevanovic, R. | 2011
PCN28 Capecitabine for the Treatment of Breast Cancer in Private Health System in Brazil: Cost analysis Based on Real World Data
Clark, O. / Clark, L. G. / Botrel, T. E. / Rosa, B. / Medina, P. / Paladini, L. / Fiol, E. / Rodrigues, N. / Faleiros, E. / Castro, A. P. | 2011
PCN46 Cost of Metastatic Prostate Cancer Treatment in the 12 Months Following Diagnosis per Patient in Russian Federation
Yagudina, R. / Kulikov, A. / Kogon, L. | 2011
PCN72 Cost - Effectiveness Analysis of Cervical Cancer Vaccination Strategies in Spain
Garc&#x00ED / a-Jurado, L. / Morano, R. / Torn&#x00E9 / A. / Malvar, A. / Bayas, J. M. / Casado, M. A. | 2011
PCN96 Costs of Adjuvant Chemotherapy with Oxaliplatin in Stage III Colon Cancer: Comparing the Three Schemes Standards: FOLFOX-4, FLOX and XELOX
Calderillo, G. / Melchor, J. / Ruiz, E. / Meneses, A. / Albarran, A. | 2011
PRS55 Further Developments of the Living with Chronic Obstructive Pulmonary Disease (LCOPD)
Crawford, S. R. / McKenna, S. / Twiss, J. / Oprandi, N. C. / Tammaru, M. | 2011
PSS9 The Burden of Age-related Macular Degeneration in the Netherlands
Boland, M. R. / Vingerling, J. / Groot, M. / Hakkaart-van Roijen, L. | 2011
VA2 Cost Effectiveness Analysis of Vaccination Programs With 10-Valent (PCV10) and 13-Valent (PCV13) Pneumococcal Vaccines in Bogotá, Colombia
Torres, C. / Jaramillo, J. / Coronell, W. / Gutierrez, M. V. / Caceres, H. A. | 2011
PMH3 Cost-Effectiveness Of Paliperidone Palmitate For The Treatment Of Schizophrenia In MÉxico
Reyes-Lopez, A. / Querol, J. | 2011
PCV8 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison with Dabigatran Under the Brazilian Private Health Care System Perspective
Schiola, A. / Silva, A. P. / Santoni, N. B. / Paladini, L. / Teich, V. / Pepe, C. / Rocha, M. M. | 2011
PHP17 Mexico'S National and Institutional Essential Medicine Lists
Rivas, R. | 2011
PHP33 Knowledge, Attitude, and Practices (KAP) of Food Practitioners on Hazard Analysis and Critical Control Point (HACCP) in the Kumasi Metropolis, Ghana
Agyei-Baffour, P. / Boateng, K. / Nakua, E. / Otupiri, E. / Owusu-Dabo, E. | 2011
PSY5 Estudio Costo-Efectividad Del Parche De LidocaÍna Como Terapia Adyuvante A Pregabalina Y Gabapentina En El Manejo Del Dolor NEUROPÁtico PERIFÉrico En El Hospital San José De Bogotá D.C. Enero-Diciembre 2010
Hinestrosa, F. / Garzon, L. | 2011
PCN146 Good Prognosis, Good Quality of Life? – Longitudinal Assessment of Quality of Life in Thyroid Cancer Patients
Gamper, E. M. / Giesinger, J. M. / Oberguggenberger, A. / Wintner, L. / Singer, S. / Buxbaum, S. / Waitz, D. / Putzer, D. / Nilica, B. / Virgolini, I. | 2011
PCN152 Can Breast Cancer Risk Prediction Reduce the Risks of False Negative and False Positive Screening Mammograms?
Armstrong, K. / Handorf, E. / Chen, J. / Bristol-Demeter, M. | 2011
PRS5 Analysis Of Efficacy and Safety of Dornase Alfa in The Treatment of Cystic Fibrosis
Kaczor, M. / Wojcik, R. / Rolka, M. / Banas, P. / Niewiara, L. / Kaczynski, L. / Russel-Szymczyk, M. / Szkultecka-Debek, M. | 2011
PRS7 Efficacy and Safety of Sildenafil Above 60 mg Daily in Pulmonary Arterial Hypertension Treatment - a Systematic Literature Review
Cukier, F. N. / Fernandes, R. A. / Takemoto, M. L. / Takemoto, M. M. / Fujii, R. K. / Mould, J. F. | 2011
PRS17 Prevalence and Cost of Severe Chronic Hand Eczema Refractory to Topical Potent Corticosteroids
Cortesi, P. A. / Scalone, L. / De Pit&#x00E0 / O. / Angelini, G. / Cristaudo, A. / Girolomoni, G. / Gola, M. / Ayala, F. / Cannav&#x00F2 et al. | 2011
PRS24 Impact Of Age and Patient Co-Morbidities on Community Acquired Pneumonia (CAP) Related Costs at the Hospital Setting in a Well Defined Area Of Barcelona (Badalona, Spain)
Sicras-Mainar, A. / Guijarro, P. / de Salas-Cansado, M. / Cifuentes-Otero, I. / Navarro-Artieda, R. | 2011
PSS26 The Use of A Mixed-Treatment Comparison to Assess the Cost-Effectiveness of Ozurdex® (Dexamethasone Intravitreal Implant in Applicator) Compared With Bevacizumab Intravitreal Injections for Patients With Macular Oedema Following Branch Retinal Vein Occlusion
Almond, C. / Hayward, E. / Freemantle, N. / Brereton, N. J. | 2011
PMH57 Association of Antidepressant-Related Weight Gain with Degree of Enjoyment and Satisfaction Regarding General Daily Activities, Medication and Overall Quality of Life
Schneider, G. / Roy, A. / Dabbous, O. H. | 2011
PMS30 Cost-Effectiveness of Tocilizumab Compared to Standard Therapeutic Sequences for the Treatment of Moderate/Severe Rheumatoid Arthritis (RA) Patients in Portugal
Diamantopoulos, A. / Andrade, S. / Bernardo, A. / Branco, J. / In&#x00EA / s, L. / Pereira da Silva, J. A. / Santos, M. J. / Monteiro, I. | 2011
PMH81 Cost-Effectiveness Analysis of Antidepressants by the IQWIG in Germany
Akmaz, B. / Kessel-Steffen, M. / Friede, M. / Weidenauer, H. / Fl&#x00FC / renbrock, W. | 2011
PHP127 Impact of Patient Access Schemes on NICE and SMC Guidance
Cooke, C. L. | 2011
PRS52 Inpatient Hospital Care or Hospital-At-Home for COPD Exacerbations: A Discrete Choice Experiment
Goossens, L. / Rutten-Van M&#x00F6 / lken, M. | 2011
PRS66 Drug Use Review in Patients with Bronchial Asthma - the Introduction of the Optimization Program of Therapy
Oskina, E. | 2011
CN4 Evaluacion De Costos Del Tratamiento De Primera Linea Para Cancer Colorrectal Metastasico (Mcrc) Con Esquemas Basados En: Folfiri, Folfox O Xelox Mas Bevacizumab, En Cinco Instituciones Mexicanas
Ruiz, G. C. | 2011
PCV26 Real World Add-On and Switch Patterns for Platelet Aggregation Inhibitors
L&#x00F6 / froth, E. / Bruce, S. / Myr&#x00E9 / n, K. J. | 2011
PND53 The Patient-Reported Burden of Impaired Walking in Multiple Sclerosis
Moorcroft, E. / Kennedy, K. / Miller, D. W. / White, J. / Sidovar, M. | 2011
PUK2 Comparative Effectiveness of Investigational Compound Ferumoxytol for the Treatment of Iron Deficiency Anaemia in Chronic Kidney Disease: Systematic Review and Mixed Treatment Comparison
Stradwick, S. / Hartmann, J. / Morgan, A. / Freemantle, N. | 2011

Wie erhalte ich diesen Titel?

Feedback